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ABSTRACT
Sphingolipid Metabolism and Insulin Resistance in Dairy Cattle
Jorge Eduardo Rico Navarrete

During their productive and reproductive life cycles, dairy cows naturally undergo physiological
adaptations that facilitate modifications of nutrient flux to sustain the energy demands of gestation
and lactation. The onset of lipolysis from adipose tissue is necessary to sustain tissue energy supply
while cows experience sustained negative energy balance during early lactation. Excessive
lipomobilization, however, predisposes dairy cows to metabolic disease during postpartum,
leading to poor health, reduced productive and reproductive performance, increased rates of
culling, and economic losses for the industry. In monogastrics, ceramides are implicated in the
pathogenesis of insulin resistance, and are associated with saturated fatty acid availability and the
onset of metabolic diseases. To date, the role of ceramides and its association with insulin action
during peripartum and established lactation, have not been investigated in dairy cows. The studies
presented in this dissertation evaluate the associations between fatty acid availability, ceramide
synthesis, and insulin action. In the first and second experiment, we established that increased
body fat accumulation results in elevated circulating NEFA, ketone bodies and liver fat
accumulation, reduced plasma sphingomyelin, and increased ceramide content in plasma, liver and
skeletal muscle. Ceramides were inversely associated with circulating insulin and insulin
sensitivity. Time-specific effects were observed for insulin ceramide accumulation, which
increased during the transition from gestation to lactation, and were independent of adiposity.
Similarly, plasma sphingomyelins, a source of ceramides, decreased toward parturition and
increased postpartum. Ceramide accumulation in plasma was associated with hepatic fat
accumulation and hepatic ceramide availability. In the third experiment, the effects of feeding
palmitate (C16:0; 4% of ration DM) were characterized in dairy cows during mid-lactation.
Palmitate supplementation resulted in increased hepatic accumulation of ceramides and
modulation of genes related to ceramide synthesis. Similarly, palmitate supplementation increased
circulating ceramide concentration, a response both positively associated with milk yield and
negatively associated with circulating NEFA disappearance during an intravenous glucose
challenge. Interestingly, palmitate supplementation delayed time-associated decrease of
circulating ceramide during lactation. Collectively, these results demonstrate that availability of
circulating fatty acids can impact ceramide synthesis and suggest that insulin action is associated
with ceramide accumulation. Moreover, time-dependent changes occur in sphingolipid availability
during the cow life cycle, indicating a possible role of ceramides in the physiological adaptations
that allow preservation of energy homeostasis. These studies provide a framework for the study
peripartal and lactational insulin resistance in association with sphingolipid metabolism.
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Chapter 1
INTRODUCTION
The historical interest in optimizing milk production systems has led to the implementation of
improved management practices, better nutrition and intense genetic selection. Over the last
century, individual milk yield has increased from nearly 3000 kg to more than 8000 kg per cow
per year, while greatly reducing the number of animals required to sustain the growing market
demands (Capper et al., 2009). The elevated genetic merit for milk production has led to a
simultaneous increase in energy requirements of cows to sustain lactation energy requirements,
and has imposed more severe negative energy balance over longer periods of time during early
lactation (Coppock and Wilks, 1991). In consequence, modern dairy cows experience reduced
reproductive efficiency and higher propensity for metabolic stress and metabolic disease (Leroy et
al., 2008; LeBlanc, 2010; Sordillo and Raphael, 2013). Although adipose tissue lipolysis is an
important mechanism allowing the use fatty acids to contribute energy to peripheral tissues and to
maintain glucose homestotasis, it is recognized that excessive lipomobilization predisposes dairy
cows to metabolic stress and disease (Ospina et al., 2010a; Dechow et al., 2004), and it is directly
related to body adiposity (Kim and Suh, 2003) and the extent of adipose tissue-specific insulin
resistance during peripartum (Zachut, et al., 2013). The association between circulating lipids,
body fat accumulation, and insulin resistance is well established in monogastrics and ruminants
(Boden et al., 1991; Oikawa and Oetzel, 2006; Pires et al., 2007a), and it constitutes a major factor
underlying the pathogenesis of the metabolic syndrome in human obesity (Varman et al., 2010).
In particular, saturated fatty acids (SFA) can impair insulin action by causing decreased pancreatic
insulin secretion and by inducing peripheral insulin resistance. These effects are largely driven by
the accumulation of ceramides, sphingolipids that accumulate during obesity and disrupt cellular
1

insulin signaling and insulin secretion (Sjoholm, 1995; Kleppe, et al., 2003; Bikman and Summers,
2011). Therefore, we aimed to study the associations between sphingolipid metabolism, fatty acid
availability, and insulin action in overweight dairy cows. In addition, because lipid availability can
be manipulated through the diet, we explored the effects of fat supplementation on ceramide
metabolism as a mean to sustain the physiological insulin resistance that accompanies lactation
and facilitates milk yield. In order to achieve our objectives, we employed a mass spectrometrybased lipidomics approach, which has been extensively utilized to characterize the roles of
sphingolipids in metabolism, and their involvement in the pathogenesis of insulin resistance
(Merril et al., 2005; Hannun and Obeid, 2008). We thus aimed to identify the most relevant
ceramide forms associated with fatty acid availability and insulin action during the critical
peripartal period and during established lactation in dairy cows.
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Chapter 2
LITERATURE REVIEW

Energy Metabolism in the Dairy Cow
From a digestive physiology perspective, dairy cows can be as defined pre-gastric
fermentation herbivores. The development of the rumen as a pregastric fermentation chamber,
which houses a complex microbial ecosystem, allows cows to utilize fiber and fiber-associated
nutrients. This remarkable symbiotic relationship provides the dairy cow with otherwise
unavailable metabolizable energy sources, such as the volatile fatty acids acetate, propionate and
butyrate, as well as with high quality protein of microbial origin.
In dairy cows, most of circulating glucose is utilized by the skeletal muscles, the gravid
uterus, and the udder, with the latter accounting for 50-85% of whole-body glucose needs during
early lactation (De Koster and Opsomer, 2013). Because of the extensive fermentation of dietary
glucose by ruminal microorganisms, intestinal absorption of glucose is negligible (Mills et al.,
1999), particularly when compared with non-ruminants (Aschenbach et al., 2010). In consequence,
circulating glucose is typically low (Annison and White, 1961, Zachut et al 2013; Hammon et al.,
2009), and cows rely heavily on endogenous glucose production through gluconeogenesis
(Aschenbach et al., 2010), a process that predominantly utilizes circulating propionate (60-74% of
total de novo glucose). Endogenous glucose production is paramount because it allows glucose
supply to reach organs that rely solely on glucose as an energy source, such as red blood cells,
brain cells, and kidney cells (Aschenbach et al., 2010). Importantly, hepatic glucose production
accounts for the vast majority of circulating glucose required during late gestation and early
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lactation, a period in which glucose requirements can increase 3- to 4-fold in modern dairy cows
(Bell, 1995; Reynolds et al., 2003).
The transition from gestation to lactation imposes a great metabolic challenge for modern
dairy cows, whose energy requirements can typically double as lactation is initiated (Drackley et
al., 2005). Because dry matter, and therefore, nutrient intake, is decreased around parturition,
transition dairy cows experiencing increased energy demands will commonly undergo negative
energy balance (NEB) during this period (Grummer et al., 2004). This condition results in an
increased use of energy from body tissues, such as adipose (lipolysis) and skeletal muscle (amino
acid breakdown), as well as increased hepatic gluconeogenesis (Graber et al., 2010), all of which
favor the production of glucose for lactose synthesis in the mammary gland (Bell, 1995). One of
the hallmarks of NEB postpartum is the elevation in the concentration of circulating non-esterified
fatty acids (NEFA), mobilized from adipose tissue triacylglycerols (TAG). Adipose tissue
metabolism shifts from lipogenic to lipolytic during this period (McNamara, 1991), and this
process is facilitated by changes in the levels of plasma homeorhetic hormones (Tucker, 1985), a
decrease in insulin concentration, and a progressively increased refractoriness of peripheral tissues
to the action of insulin (Bell and Bauman, 1997). In addition, adipose tissue sensitivity to lipolytic
hormones such as epinephrine and norepinephrine is greatly enhanced, while circulating glucagon
concentrations increase (Drackley et al., 2005; De Koster and Opsomer, 2013; Mann et al., 2016)
The central role of the liver in energy metabolism is well exemplified during the transition
from gestation to lactation. In addition to being a major gluconeogenic organ, the liver can also
take up and metabolize circulating NEFA from adipose tissue TAG mobilization. Once NEFA
enter the liver, fatty acids can be oxidized, serve as a carbon source for ketogenesis, or be
reesterified into TAG (Drackley et al., 2005). Because ruminants have an inherently low capacity
4

to export TAG to circulation through very low density lipoprotein secretion (VLDL; Kleppe et al.,
1988; Pullen et al., 1989), excessive NEFA uptake can result in TAG accumulation and fatty liver
may develop (Bobe et al., 2004). In addition, excessive NEFA uptake from NEB can result in
increased synthesis of ketone bodies (e.g. BHBA) leading to ketosis and associated health
disorders, such as mastitis, metritis, milk fever, and displaced abomasum (Herdt, 2000; Bobe et
al., 2004).
The incidence of disorders of energy metabolism is greatest during the transition from late
gestation to early lactation. Although the dairy cow is physiologically well suited to respond to the
elevated glucose demands of the mammary gland during early lactation, intense genetic selection
for elevated milk yield has led to ever more dramatic changes in metabolic activity associated with
severe NEB. Pronounced metabolic adaptations to NEB, such as excessive lipolysis, are associated
with dysfunctional immune responses, metabolic stress, and metabolic disease (Sordillo et al.,
2009; Contreras et al., 2010; Sordillo et al., 2013). In this context, it is argued that the ability of
the dairy cow to compensate for the gap between nutrient demand and energy supply has been
historically overstressed, bringing about increased incidence of metabolic disorders (Sundrum,
2015).
The use of metabolic markers during prepartum has the potential to aid in the identification
of early manifestations aberrant metabolism that will ultimately result in peripartal health
disorders, and thereby guide herd management modifications to reduce the incidence of disease.
Currently used indicators of metabolic stress, as well as subclinical and clinical metabolic disease,
include the stress and inflammation marker haptoglobin, and the NEB markers NEFA and BHBA
(Huzzey et al., 2015; Ospina et al., 2010a, Ospina et al., 2010b). However, the identification of
pre-onset markers of metabolic abnormalities associated with increased susceptibility of cows to
5

suffer from peripartal health complications is still needed. As mentioned previously, excessive
lipolysis drives elevated circulating NEFA and can result in fatty liver and associated
complications postpartum. Recent research shows that adipose tissue insulin resistance is
associated with increased lipolysis in cows prone to lose excess body weight postpartum (Zachut
et al., 2013). Overweight cows are more susceptible to lose body weight and adiposity during
peripatum (Kim and Suh, 2003; Roche et al., 2009), and are at a higher risk of developing
postpartum health disorders and experiencing reduced productive and reproductive performance
postpartum (Fronk et al., 1980; Kim and Suh, 2003; Roche et al., 2009). The association between
fat mass accumulation and metabolic disease in dairy cows has been recognized for decades and
denominated ‘fat cow syndrome’ (Morrow, 1975). Interestingly, the symptomatology of this
syndrome resembles that usually observed in overweight and obese humans diagnosed with
metabolic syndrome (Boucher et al., 2104). Common features include abnormal levels of blood
lipids, hepatic fat accumulation and reduced insulin action (Ohtsuka et al., 2001; O’Boyle et al., 2006;
Boucher et al., 2014). Given the major role of insulin in the pathogenesis of metabolic disease it
has been suggested that the term ‘insulin resistance syndrome’ should be used to better describe
insulin’s major role in the onset of disease (Reaven, 1988). Because insulin is a central regulator
of energy metabolism during this critical period, understanding of factors affecting insulin
secretion and action is a necessary step to better understand the etiology of peripartal disease in
dairy cows.
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Metabolic Roles of Insulin
Insulin is an anabolic peptide hormone composed of 110 aminoacid residues, and it is
synthesized in the β-cells of the pancreatic islets of Langerhans in response to circulating
segregatogues. Its primary structure was first determined by Frederick Sanger in 1951, and it
consists of two polypeptide chains, called A- and B- chains, linked together by two disulfide bonds
(Sanger and Tuppy, 1951). Insulin is encoded as preproinsulin by the INS gene, and its structure
has remained highly conserved across vertebrates for over 400 million years (Steiner et al., 1985;
Ebberink et al., 1989; Zhang and Steiner., 2000). In fact, bovine insulin differs from human insulin
in three aminoacid residues, while porcine insulin does so in only one. This strong homology is
suggestive of a fundamental role of insulin as a vital metabolic signal throughout animal
evolutionary history.
Insulin signals several body tissues, from the brain to liver, skeletal muscle, and adipose
tissue. Globally, insulin acts as an anabolic hormone, promoting energy storage and suppressing
catabolism in insulin-sensitive tissues. Although the effect of insulin on glycemic control is its
most commonly discussed function, insulin governs a multitude of cellular processes to maintain
energy homeostasis. The major effects of insulin on liver, adipose tissue and skeletal muscle
include: (a) increased rate of glucose transport across the cellular plasma membrane, (b) increased
rates of glycolysis, (c) stimulation of glycogen synthesis, suppression of glycogen breakdown and
hepatic gluconeogenesis, (d) reduction in rates of adipose tissue lipolysis, (e) stimulation of de
novo lipogenesis, TAG synthesis, and circulating NEFA uptake in adipose tissue and muscle, (f)
reduction of fatty acid oxidation in muscle and liver, (g) increased rates of amino acid transport
into tissues and protein synthesis, and (h) reduction of protein degradation rates in muscle
(Edgerton et al., 2006; Dimitriadis et al., 2011). In order to exert its anabolic actions, insulin is
7

released into circulation and sensed by the insulin receptor, which relays the insulin signal into the
cells by promoting phosphorylation and activation of downstream target proteins (Figure 2-1).
The insulin receptor is a transmembrane protein that belongs to the broader family of
receptor tyrosine kinases (Ullrich et al., 1985; Lemmon and Schlessinger, 2010). The receptor is
a heterotetrameric glycoprotein consisting of two α-subunits and two β-subunits linked by disulfide
bonds. The α-subunits are extracellular and contain the insulin binding site, whereas the β-subunits
span the plasma membrane and are involved in intracellular signaling (Hedo and Simpson, 1984).
The insulin receptor is widely distributed on mammalian tissues, and its concentration varies from
as few as 40 receptors on red blood cells to more than 200,000 receptors on adipocytes and
hepatocytes (Khan and White, 1988). Insulin action in target tissues is initiated by a highly specific
binding to the insulin receptor (Freychet et al., 1971; Czech, 1984; Menting et al., 2013).
Interestingly, the binding properties of the insulin receptor in vertebrates are better evolutionarily
conserved than are the functional properties of insulin itself (Muggeo et al., 1979).
When insulin binds to the α-subunit of the insulin receptor, the intracellular β-subunit
becomes activated by phosphorylation of certain tyrosine residues, a process that is commonly
described as autophosphorylation, and which results in kinase activity activation of the β-subunits
and further recruitment of receptor substrates (Kasuga et al., 1982; Ward and Lawrence, 2009;
Figure 2-1). The insulin receptor substrates (IRS-1 through IRS-6) are a family of proteins with no
intrinsic enzyme activity and act as scaffolds to mediate signaling complexes (Sun et al. 1991;
White, 2006; Shaw, 2011). The activated receptor recruit IRS proteins to the cellular membrane
and subsequently phosphorylate them on multiple tyrosine residues, forming binding sites for
intracellular molecules that contain Src-homology 2 (SH2) domains (Sun et al., 1993). Upon IRS
phosphorylation, phosphatidyl inositol 3-kinase (PI3K), a heterodimer with catalytic and
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regulatory subunits, is recruited and activated. The activation of PI3K depends on the binding of
the two SH2 domains in the regulatory subunits (predominantly p85α) to tyrosine-phosphorylated
IRS proteins (Myers et al. 1992; Shaw, 2011). This results in activation of the catalytic subunit
(p110), which rapidly phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to generate the
lipid second messenger phosphatidylinositol (3,4,5)-triphosphate (PIP3). The presence of these
residues attracts molecules that express pleckstrin homology (PH) domains, such as protein kinase
B (Akt), which translocates to the inner leaflet of the plasma membrane and then binds with high
affinity to 3-phosphoinositides. This process induces a conformational change that makes Akt
susceptible

to

phosphorylation.

Membrane-bound

PIP3

recruits

and

activates

the

phosphoinositide-dependent kinase-1 (PDK-1), which phosphorylates Akt on threonine 308, in
addition to PDK-2, which phosphorylates on serine 473, rendering Akt fully active (Saltiel and
Kahn, 2001; Petersen and Shulman, 2006). Active Akt promotes the effects of insulin on several
downstream proteins including the mammalian target of rapamycin-C1 (mTORC1), sterol
regulatory binding-element protein-1c (SREBP1c), glycogen synthase kinase-3 (GSK-3), Akt
substrate 160 (AS160), and the forkhead box protein 01 (Fox01). The major results of Akt
activation include activation of lipogenesis, glycogen synthesis, glucose transport via the glucose
transporter 4 (GLUT4), and the inhibition of gluconeogenesis and glycogenolysis (Figure 2-1).
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Figure 2-1. Insulin signaling pathway.
Activation of the insulin receptor by its ligands initiates a cascade of phosphorylation events which
promote the metabolic effects of insulin. Abbreviations: Insulin receptor substrate (IRS), SHCtransforming protein (SHC), mitogen-activated protein kinase (MAPK), Protein kinase B (Akt),
phosphoinositide-dependent kinase-1 (PDK1), phosphoinositide-dependent kinase-2 (PDK-2),
mammalian target of rapamycin-C1 (mTORC1), sterol regulatory binding-element protein-1c
(SREBP1c), glycogen synthase kinase-3 (GSK-3), Akt substrate 160 (AS160), forkhead box
protein O1 (FoXO1), glucose transporter 4 (GLUT4). Adapted from Turner, 2013.

Insulin Secretion and Sensitivity in Dairy Cattle
In association with a unique digestive physiology, ruminants have co-evolved metabolic
adaptations which allow them to maintain energy homeostasis under conditions of chronicallylimited exogenous glucose supply. The regulatory role of insulin on metabolism, for example, is
preserved by the activation of alternative metabolic signals that can promote its release.
Propionate, a major gluconeogenic substrate derived from ruminal fermentation of carbohydrates,
is a potent insulin segregatogue in ruminants, and thus constitutes an important energy-sensing
signal (Hertelendy et al., 1968; Sano et al., 1999; Bradford et al., 2006). The importance of
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circulating propionate on insulin secretion is underscored by the observation that pancreatic
responsiveness to propionate is higher than that to glucose itself (Manns and Boda, 1967).
The glucoregulatory response of peripheral tissues to insulin signals is also comparatively
low in ruminants, relative to non-ruminants (Annison and White, 1961; Kaske et al., 2001, Sasaki,
2002). The fact that ruminants maintain a homeostatic status in spite of reduced insulin action
seems paradoxical. This resistance to the stimulatory action of insulin on glucose metabolism may
be due to the lower content of GLUT4 and the lower capacity of insulin signal transduction, which
results in lower glucose transport activity (Sasaki, 2002), and may be reflective of a constantly
reduced glucose supply to insulin-sensitive tissues.

Changes in Insulin Secretion and Action During Pregnancy and Lactation
As mentioned previously, major shifts in nutrient partitioning are required to support fetal
growth and milk synthesis during the peripartal period (Bauman and Currie, 1980; Bell, 1995).
These metabolic shifts encompass changes in circulating endocrine regulators, such as growth
hormone, estrogens, progesterone, and insulin, among others (Tucker, 1985). The process is
known as homeorhesis, and it was first proposed by Waddinton in 1957 as ‘flow toward a new
equilibrium’, in a clear analogy to the equilibrium of homeostasis. Bauman and Currie crystalized
the concept as ‘the orchestrated changes in metabolism of body tissues necessary to support a
physiological state’ (Bauman and Currie, 1980). Insulin plays a major role in the regulation of
macronutrient tissue metabolism, and it is fundamentally involved in homeostasis and homeorhesis
during peripartum (Bauman Currie, 1980). Both insulin concentration and insulin responsiveness
change dynamically during the transition from gestation to lactation (Bauman and Currie, 19080;
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Bell, 1995; Bell and Bauman, 1997; Figure 2-2). Indeed, insulin secretion is elevated during the
majority of pregnancy and decreases as parturition approaches in several animal species, including
cows and humans (Bell and Bauman, 1997; Homko et al., 2001; Zachut et al., 2013). Similarly, it
is well recognized that insulin resistance develops during late pregnancy in monogastrics (Ryan et
al., 1985; Sevillano et al., 2007), while in the dairy cow, postpartum insulin sensitivity is
effectively lower than during prepartum (Bell and Bauman, 1997; Kerestes et al., 2009).
Importantly for dairy cows, reduced insulin action results in increased hepatic gluconeogenesis
and increased adipose tissue lipolysis, both of which favor the preservation of energy homeostasis
during the unavoidable progression of postpartum NEB (Figure 2-2). Recent evidence
demonstrates that localized insulin resistance occurs in the adipose tissue of early lactation dairy
cows, mechanistically driven by decreased tyrosine phosphorylation of IRS-1 (Ji et al., 2012;
Zachut et al., 2013).

Figure 2-2. Changes in insulin secretion, insulin sensitivity and circulating NEFA during the cow
life cycle.
Abbreviations: Non-esterified fatty acids (NEFA).
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Mechanism of Insulin resistance
The major mechanisms driving insulin resistance will be discussed briefly. For an
extended reading, the reviews by Hotamisligil, 2006, Varman et al., 2010, De Koster and
Opsomer (2013), and Boucher et al. (2014), are recommended.

Genetic Factors
Point mutations in the insulin receptor and insulin signaling molecules such as IRS, PI3K,
PDK2 and AS160 result in increased protein turnover, reduced expression and ligand affinity, and
decreased insulin signaling capacities, all described in severe genetic forms of insulin resistance
(Boucher et al., 2014). Similarly, single nucleotide polymorphisms of the protein phosphatase
tensing homolog (PTEN) lead to reduced Akt activation and associated downstream proteins via
reduced PIP3 levels (Ishihara et al., 2003). Interestingly, genetic haploinsufficiency of PTEN
results in reduced dephosphorylation of PI3K and enhanced insulin sensitivity in obese individuals.
Although these subjects do not develop type 2 diabetes, they display a higher propensity to develop
cancer (Pal et al., 2012). Similar to humans, genetic influences may modulate insulin sensitivity
in dairy cattle. For example, cows with high genetic merit for milk production are known to be
more insulin resistant that cows with a low genetic merit for milk production (Chagas et al., 2009).
However, little is known of the specific genes responsible for these differences in insulin
sensitivity. Further investigation is needed to characterize gene variants responsible for increased
insulin resistance, as well as their role in the onset of metabolic disease.
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Hyperglycemia, Hyperinsulinemia, Inflammation and Cellular Stress
Supraphysiologycal concentrations of circulating glucose result in decreased insulin action
in adipose tissue and skeletal muscle, both in vivo and in vitro (Leahy et al., 1986; Hager et al.,
19991; Robinson and Buse, 2008). Because hyperglycemia is a hallmark of peripheral insulin
resistance, it is conceivable that the negative effects of glucose on insulin signaling (i.e.
glucotoxicity) are secondary to other initial causes. This implies that glucose is part of a negative
cycle that exacerbates initial insulin resistance. Interestingly, inhibition of glucose transport by
inactivation of GLUT4 in rats can cause secondary defects in insulin action in adipose tissue and
liver (Kim et al., 2001). Mechanistically, hyperglycemia results in glycation and O-GlcNAcylation
of insulin signaling proteins, reduced receptor affinity, increased Ser-307 phosphorylation IRS-1,
decreased binding of transcription factors, and increased protein phosphatase 2-A activity
(Boucher et al., 2014). In addition, hyperglycemia can increase the activity of cellular
phosphatases, such as PP2A and PTEN, causing reduced phosphorylation of Akt (Robinson and
Buse, 2008; Kowluru and Matti, 2012).
Insulin can have dampening effects on its own pathway. This process is known as
homologous desensitization and posits that continuous exposure of the target cells reduces the
ability of insulin to stimulate signal transduction at the level of the receptor (Shanik et al., 2008).
This negative feedback loop involves reduced receptor affinity, lower number of receptors on the
cell surface, and decreased ability of the receptor to transmit stimulatory signals. These processes
encompass negative cooperativity of insulin binding (De Meyts et al., 1973; De Meyts et al., 1976),
increased internalization and degradation of hormone occupied receptors (Gavin et al., 1974),
reduced receptor kinase activity, and inactivation of downstream kinases via Ser and Thr
phosphorylation events (Zick et al., 1983; Paz et al., 1997; Boucher et al, 2014).
14

Chronic low-grade inflammation is a prominent characteristic of obesity, and it is
considered to be a major component in promoting obesity-associated insulin resistance
(Hotamisligil, 2006; Osborn and Olefsky, 2012). Inflammation is characterized by abnormal
cytokine production (e.g. TNF-α), acute phase reactants (e.g. haptoglobin), and activation of a
network of inflammatory signaling pathways (Wellen and Hotamisligil, 2005; Sordillo and
Raphael, 2013, De Koster and Opsomer, 2013). Adipocytes and macrophages are central cell types
in the pathogenesis of insulin resistance in obesity. Typically, macrophages are recruited and
infiltrate the adipose tissue promoting a state of inflammation, leading to secretion of
proinflammatory cytokines and inducing insulin resistance (Schenk et al., 2008). In dairy cows,
the peripartal period is associated with a high degree of inflammation (Bertoni et al., 2008) which
can be exacerbated in overweight individuals and those diagnosed with fatty liver, leading to
elevated NEFA, increased TNF-α activity, insulin resistance and metabolic disorders (O’Boyle et
al., 2006; Ohtsuka et al., 2001).
Cellular stress is a well characterized cause of insulin resistance, and it is manifested by
mitochondrial oxidative stress and endoplasmic reticulum (ER) stress (Evans et al., 2005; Jheng
et al., 2012; Ozcan et al., 2004). Unresolved reactive oxygen species (ROS) accumulation causes
oxidative stress in the mitochondrion, and results in alterations of mitochondrial proteins and
reduced expression and activity of antioxidant enzymes (i.e. mitochondrial dysfunction; Evans et
al. 2005; Fridlyand and Philipson 2006). Oxidative stress causes activation of stress kinases that
induce serine phosphorylation and insulin resistance at the level of IRS proteins (Rudich et al.
1998; Evans et al. 2005; Dokken et al. 2008). In the liver, specifically, oxidative stress reduces FA
oxidation and can lead to diacylglycerol (DAG) accrual, PKC-1 activation and decreased IRS-2
phosphorylation and PI3-kinase activity (Koh et al. 2005; Zhang et al. 2007). The unfolded protein
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response (UPR) of the ER, is cellular process that ensures proper protein folding, maturation and
quality control, and it is activated to reduce the unfolded protein load (Hotamisligil, 2010). Obese
mice display increased activation of UPR pathways, which leads to inflammatory pathway
activation (e.g. JNK and IKK) and insulin resistance via serine 307 phosphorylation of IRS-1
(Ozcan et al. 2004; Zhang et al. 2008).
Of note, the aforementioned mechanisms causing insulin resistance all converge in the
activation of serine/threonine kinases, which leads to inhibitory phosphorylation of the insulin
receptor, IRS proteins, and Akt, and thereby results in disruption of insulin signaling (Boucher et
al., 2014).

Lipotoxicity
An important feature of the metabolic syndrome in monogastrics is the ectopic
accumulation of lipids, particularly of fatty acids, as a causal factor of insulin resistance commonly
associated with obesity (DeFronzo, 2004; Boucher et al., 2014). In dairy cows, the association
between fat accumulation and insulin resistance was first demonstrated by MCann and Reimers
(1985), who reported lower reduction of glucose following and intravenous challenge in obese
heifers. Tissue accumulation of lipids constitutes a direct link for the known association between
elevated circulating fatty acids and insulin resistance (Boden et al., 1991; Roden et al., 1996;
Schenk et al., 2008; Figure 2-3). The effects of fatty acids, in particular, are facilitated by ectopic
fat accumulation, which, besides causing insulin resistance, can result in increased lipolysis, β-cell
dysfunction and perturbations of fatty acid oxidation, a cluster of abnormalities denominated
lipotoxicity (Unger, 2003; DeFronzo, 2004; Wellen and Hotamisligil, 2005). Manifestations of
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lipotoxicity in non-adipose tissues are due to increased lipid transport into tissues and result in
skeletal muscle insulin resistance (Ferreira et al. 2001), lipotoxic cardiomyopathy and fatty liver
disease (Chiu et al. 2005; Koonen et al. 2007). In dairy cows, elevated NEFA is associated with
the development of insulin resistance (Kerestes et al., 2009). Interestingly, both the use of
hypercaloric diets and intravenous lipid infusion,induce elevation of plasma NEFA and result in
insulin resistance (Holtenius et al., 2003; Pires et al., 2007a). Ultimately, increased NEFA results
in serine phosphorylation of IRS-1, decreased downstream phosphorylation events and disruption
of insulin signal transduction (Le Marchand-Brustel, et al., 2003). The effects of circulating NEFA
on insulin sensitivity in different tissues are mediated by lipid intermediates formed upon cellular
activation (i.e. fatty acyl CoAs), and include ceramides, DAG, and, probably, acylcarnitines
(Holland and Summers, 2008; Erion and Shulman, 2010; Mihalik et al., 2010). When the flux of
fatty acids (e.g. accelerated lipolysis in adipose tissue) outpaces the ability of the pathways to
dispose of fatty acyl-CoAs, these intermediaries of fatty acid metabolism can accumulate (Schenk
et al., 2008; Figure 2-3).
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Figure 2-3. Lipotoxic theory of insulin resistance in myocytes and hepatocytes.
Abbreviations: Carnitine palmitoyl acyl transferase-1 and -2 (CPT1/2), Protein kinase B (Akt).
Adapted from Schenk et al., 2008.

The effects of these lipid intermediates converge at the activation of different serine kinases,
resulting in disrupted insulin signaling. Ceramides, in particular, have gained attention as effectors
of insulin resistance because they are associated with obesity, and because, unlike DAG, they
specifically link circulating SFA availability and insulin resistance (Chavez et al., 2003).
Ceramides accumulate in insulin resistant tissues of rodents (Summers, 2006; Holland and
Summers 2008) and humans (Adams et al., 2004; Straczkowski, 2007), which results in reduced
Akt phosphorylation through its targets PP2A and protein Kinase Cζ (Chavez et al., 2003; Stratford
et al., 2004; Bourbon et al., 2002). Saturated FA are proinflammatory compounds that lead to
activation of inflammatory signaling in macrophages, adipocytes, myocytes and hepatocytes
(Hwang and Rhee, 1999; Yu et al., 2002; Nguyen et al., 2005; Nguyen et al., 2007). This leads to
stimulation of inflammatory proteins IKKβ/NFκB and JNK/AP1 and cytokines, such as tumor
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necrosis factor-α (TNF-α), via stimulation of the Toll-like receptor 4 (TLR4; Nguyen et al., 2007;
Shi et al., 2006). Of note, the mechanisms linking SFA and inflammation seem to contribute to
macrophage induced insulin resistance by converging in elevated ceramide synthesis. In dairy
cows, the adipose tissue is a primary site for inflammation, and it has the ability to produce the
inflammatory cytokines TNF-α and interleukin 6 (IL-6; Sadri et al., 2010). Although the effects of
most adipokines on insulin sensitivity in dairy cattle have not been extensively characterized, the
effects of TNF-α have been widely studied. Subcutaneous injection of TNF-α resulted in decreased
insulin sensitivity and increased hepatic TAG accumulation in dairy cows in steers and dairy cows,
respectively (Kushibiki et al 2001; Bradford et al., 2009). In addition, cows suffering from fatty
liver had increased serum NEFA and plasma TNF-α concentrations, and were more insulin
resistant relative to cows with normal fat accumulation (Ohtsuka et al., 2001). Moreover, similar
to obese humans, overweight dairy cows display elevated plasma TNF-α concentration (O’boyle
et al., 2006), providing a potential mechanistic link between fat accumulation and insulin
resistance in dairy cattle.

Sphingolipid Metabolism
Sphingolipids are a class of bioactive lipids comprised of a sphingoid base backbone,
sphinganine (an eighteen-carbon alcohol backbone; Hannun and Obeid, 2008; Figure 2-4).
Variations of this basic structure give origin to a vast and complex family of sphingolipids (e.g.
ceramides, sphingosine-1-phosphate, sphingomyelin, and gangliosides; Merrill et al., 2007), with
structural and regulatory roles, including cell growth, death, senescence, adhesion, migration,
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inflammation, angiogenesis and intracellular trafficking (Hannun and Obeid 2008). Ceramides are
formed by the N-acylation of sphingosine with fatty acids (Gault et al., 2010), in a process carried
out by the action of six different ceramide synthases (Levy and Futerman; Figure 2-4). Because
ceramide can contain differing acyl CoAs, it is considered to be a class of molecules, rather than a
single molecule, which can have different biological functions depending on the acyl chain they
contain. To date, the specific bioactive roles of ceramides with differing acyl chain FA
composition have not been completely elucidated.

Figure 2-4 Ceramide acyl chain diversity and the specificity of (dihydro)ceramide synthases.
The N-acylation of sphinganine by (dihydro)ceramide synthases results in ceramides of different
acyl chain length. CerS: Ceramide synthase. Adapted from Levy and Futerman, 2010.
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Ceramide Synthesis
The production of ceramides within the cell occurs through three major pathways: de novo
synthesis, sphingomyelin hydrolysis, and the salvage pathway (Figure 2-5). De novo ceramide
synthesis begins with the transfer of a serine residue onto a fatty acyl-CoA via serine
palmitoyltransferase (SPT), in a condensation reaction that produces 3-keto-sphinganine (3KSn;
Holland and Summers, 2008). In the subsequent reactions, (dihydro)ceramide synthases (CerS)
and dihydroceramide desaturases (Des1 and -2), catalyze the conversion of 3KSn into ceramide.
Importantly, SPT is highly selective for saturated 16-carbon moieties in several organisms
(Holland and Summers, 2008), and it is thus strongly influenced by SFA availability (Merrill,
2002). This explaining why SFA and not unsaturated fats drive the synthesis of sphingolipids
(Chavez et al., 2003). In addition, inflammatory signals, such as those produced through the
IKKβ/NFκB/TNF-α axis, upregulate SPT and can thus cause increased ceramide accumulation in
adipose tissue (Samad et al., 2006). Moreover, the effects of SFA on the upregulation of ceramide
synthesis can be also exerted through activation of the TLRs, involved in innate immune responses.
The activation TLRs by SFA results in the production of inflammatory cytokines, such as TNFα,
and IL-6, resulting in increased ceramide synthesis (Shi et al.; Senn, 2006).
The sphingomyelin hydrolysis pathway generates ceramide in a reaction catalyzed by
sphingomyelinase (SMase) enzymes differing in their optimal pH and cellular locations (Deigner
et al., 2009; Boulgaropoulos, et al., 2010). Because sphingomyelin is the most abundant
sphingolipid in mammals, its hydrolysis has the potential to greatly impact intracellular ceramide
concentrations. This pathway is upregulated in obesity through the activation of inflammatory
signals (i.e. IKKβ/NFκB/TNF-α axis), resulting in increased levels of neutral and acid SMases
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(Samad et al., 2006). Importantly, the contribution of this pathway to the accumulation of
ceramides in dairy cows has not been established.
Finally, catabolic metabolism of complex sphingolipids contributing to ceramide accrual
occurs in late endosomes and lysosomes of cells. The process, often referred to as sphingolipid
recycling or salvage (Kitatani et al., 2008), uses acid SMase and acid β-glucosidase-1 degrade
sphingomyelin and glycosphingolipids, respectively, to form ceramide within acidic cellular
compartments (Kitatani et al., 2008; Kitatani et al., 2009). Ceramide is then degraded into
sphingosine and free fatty acids (FFA), which can then enter the cytosol and be converted back to
ceramide via ceramidase activity (Riboni et al., 1998). The pathway can also work in the reverse
direction (i.e. ceramide degradation) via acid ceramidase, which deacylates ceramide to produce
sphingosine in lysosomes (Kolesnick, 2002). Although the relative importance of the salvage
pathway in determining ceramide accumulation during obesity remains unknown, evidence that
acid ceramidase overexpression can greatly increase insulin sensitivity, suggests it can potentially
impact intracellular ceramide pools (Chavez et al., 2005).
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Figure 2-5. Ceramide synthesis and degradation. Main pathways contributing to cellular
accumulation of ceramides.
Abbreviations: Sphingosine (Ss), free fatty acid (FFA). Adapted from Bikman and Summers,
2011.

Hepatic Ceramide synthesis and Secretion
The liver is considered as a primary site of ceramide synthesis, as well as a major
contributor of circulating ceramides, responsible for causing systemic insulin resistance and
reduced pancreatic insulin secretion (Watt et al., 2012; Boon et al., 2013; Holland and Summer,
2008; Figure 2-6). Similar to other lipids, hydrophobic sphingolipids are transported in the aqueous
phase or blood associated with proteins (Hammad et al., 2011). In humans, approximately 98% of
plasma ceramides are found within the apoB-containing low-, and very low-density lipoproteins
(LDL and VLDL; Iqbal et al., 2015), as well as in high density lipoproteins (HDL; Lightle et al.,
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2003; Boon et al., 2013). The mechanisms of hepatic ceramide assembly and secretion are
incompletely understood, however, recent work by Iqbal and collaborators (2015) has provided
important insights. Upon synthesis in the ER, ceramides are transported to the Golgi via ceramide
transfer protein, four-phosphate adaptor protein 2 (FAPP2), or transport vesicles for the synthesis
of sphingomyelin, glycosylated ceramides and other complex sphingolipids. Their works suggest
a primordial role of the microsomal triglyceride transfer protein in transferring ceramides and
sphingomyelins into nascent apoB-containing lipoproteins (i.e. VLDL). The mechanism by which
MTP helps incorporating ceramides into lipoproteins is thus very similar to that used to incorporate
TAG, phospholipids (PL) and cholesteryl esters (CE) into VLDL. Interestingly, palmitate has been
recently shown to increases cellular MTP levels, thus suggesting that elevated SFA availability
can not only upregulate ceramide synthesis, but it also induces its secretion from the liver
(Konstantynowicz-Nowicka et al., 2015).
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Figure 2-6. Hypothesized model of ceramide synthesis and transport into insulin-producing and
insulin-sensing tissues.

Conclusion
Dairy cows undergo dramatic metabolic adaptations in order to support changing
physiological states while preserving appropriate nutrient delivery needs. The transition from
gestation to lactation constitutes a period in which the cow’s ability to manipulate energy
metabolism is challenged, and where the importance of the modulations of insulin action is
highlighted. Along with peripartal negative energy balance, which can prolong through early
lactation, the possibility of excessive lipomobilization increases, as does the susceptibility for the
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development of metabolic disease. The central role of ceramide in inducing insulin resistance and
its association with metabolic disease in monogastrics suggests that it might have comparable
importance in dairy cows. Therefore, the objectives of this dissertation are two-fold: first, to
investigate the association between circulating ceramides and other sphingolipids with
lipomobilization and insulin action during the peripartal period, and during established lactation;
and second, to evaluate the potential to manipulate ceramide availability through dietary
modifications in order to extend physiological insulin resistance during lactation.

26

Chapter 3
PLASMA CERAMIDES ARE ELEVATED IN OVERWEIGHT HOLSTEIN DAIRY
COWS EXPERIENCING GREATER LIPOLYSIS AND INSULIN RESISTANCE
DURING THE TRANSITION FROM LATE PREGNANCY TO EARLY LACTATION

Abstract
Insulin resistance is a homeorhetic adaptation to parturition in dairy cows transitioning
from late pregnancy to early lactation. An increase in prepartum adiposity can predispose
periparturient cows to greater lipolysis and insulin resistance, thus increasing the risk for metabolic
disease. Mechanisms mediating the development of insulin resistance in overweight peripartal
dairy cows may depend on ceramide metabolism. The sphingolipid ceramide accumulates in
plasma and tissues of overweight monogastric animals, and facilitates saturated fatty acid-induced
insulin resistance. Considering this evidence, we hypothesized that plasma ceramides would be
elevated in periparturient dairy cattle and that these sphingolipids would correlate with the
magnitude of lipolysis and insulin resistance. To test our central hypothesis, multiparous Holstein
cows were allocated into 2 groups according to their body condition score (BCS) at d -30
prepartum: lean (BCS 4.0; n = 11). Blood samples were collected at d -45, -30, -15, and -7, relative
to expected parturition, and at d 4 postpartum. Plasma glucose, insulin, nonesterified fatty acids
(NEFA), and β-hydroxybutyrate (BHBA) concentrations were measured, and insulin sensitivity
was estimated. The concentrations of individual plasma ceramide and glycosylated ceramide were
determined using liquid chromatography-based mass spectrometry. Results demonstrated that
greater adiposity was associated with a greater loss in body condition during late pregnancy.
Overweight cows had greater circulating concentrations of glucose, insulin, and NEFA, and lower
1

insulin sensitivity relative to lean cows. We detected 30 different sphingolipids across 6 lipid
classes with acyl chains ranging from 16 to 26 carbons. The most abundant plasma sphingolipids
detected were C24:0-ceramide, C24:0-monohexosylceramide, and C16:0-lactosylceramide.
Plasma concentrations of total ceramide and monohexosylceramide increased as lactation
approached, and saturated ceramide and monohexosylceramide were elevated in cows with greater
adiposity relative to those with a lean phenotype. Plasma ceramides (e.g., C24:0-ceramide) were
positively correlated with plasma NEFA and inversely correlated with insulin sensitivity. Our data
demonstrate a remodeled plasma sphingolipidome in dairy cows transitioning from late pregnancy
to lactation characterized by a concomitant increase in plasma ceramides with the development of
peripartal insulin resistance.
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Introduction
Periparturient dairy cows experience an elevated demand for glucose due to an increased
requirement by the mammary gland for lactose synthesis (Bell, 1995). Dairy cattle transitioning
from late pregnancy to early lactation develop insulin resistance (Bell and Bauman, 1997) as a
metabolic adaptation to energy deficit. Insulin resistance facilitates an increase in hepatic
gluconeogenesis and a decrease in glucose uptake by skeletal muscle and adipose tissue (Bell,
1995; Spachmann et al., 2013). Consequently, circulating glucose is spared for lactose synthesis,
a major osmotic regulator of milk secretion. To increase NEFA availability for β-oxidation in
peripheral tissues and re-esterification in the mammary gland, the periparturient dairy cow
mobilizes triacylglycerol stores in adipose tissue (Drackley et al., 2005; Drackley and Andersen,
2006). Because insulin is an antilipolytic hormone, insulin resistance can further increase adipose
tissue lipolysis (Pires et al., 2007a,b). Collectively, the transition dairy cow adapts to energy
insufficiency by modifying peripheral insulin action to augment glucose economy. An increase in
prepartum adiposity can predispose dairy cows to a greater magnitude of insulin resistance during
early lactation (Holtenius et al., 2003; Holtenius and Holtenius, 2007). The greater extent of insulin
resistance in overweight peripartal dairy cows can contribute to excessive adipose tissue lipolysis
and thus greater metabolic disease risk (e.g., hepatic steatosis and ketosis). Although insulin
resistance in dairy cattle transitioning from pregnancy to lactation is mediated in part by growth
hormone (Bell and Bauman, 1997), considerable evidence supports a causative role of long-chain
saturated fatty acids as antagonists of whole-body insulin sensitivity (Boden, 1997; Funaki, 2009).
The ability of surplus saturated fatty acyl-CoA to inhibit insulin action appears to be mediated by
the structurally diverse sphingolipid ceramide (Chavez and Summers, 2012). Although ceramides
were previously believed to be merely structural elements of cell membranes, recent discoveries
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demonstrate that ceramides are directly implicated in evolutionarily conserved cellular processes,
such as cell cycle arrest, apoptosis, and stress responses (Hannun and Obeid, 2008). Ceramides
can be (1) formed by de novo synthesis initiated by the condensation of palmitoyl-CoA via action
of serine palmitoyltransferase, (2) formed by hydrolysis of sphingomyelin by either acid or neutral
sphingomyelinases, or (3) salvaged from complex sphingolipids that are broken down into
sphingosine and reacylated (Figure 1; Hirabayashi et al., 2006). An increase in palmitoyl-CoA
availability upregulates de novo ceramide synthesis and sphingomyelin hydrolysis in peripheral
tissues of obese insulin resistant mice with hepatic steatosis, responses that contribute to ceramide
accumulation in tissues and plasma (Cuschieri et al., 2007; Holland et al., 2011). The extent of
insulin resistance correlates with the concentrations of ceramide in plasma collected from obese
humans with type 2 diabetes, most notably C24:0-ceramide, which is the most abundant ceramide
species in human circulation (Haus et al., 2009). Plasma ceramide is transported as components of
low-density lipoproteins (LDL) of hepatic origin that contribute to the pathophysiology of wholebody insulin resistance. Although the mechanisms are not completely understood, an increase in
the level of LDL enriched with C24:0-ceramide decreases whole-body and skeletal muscle glucose
uptake in lean mice, a response accompanied by C24:0-ceramide accrual in the plasma membrane
and reduced insulin-stimulated protein kinase B phosphorylation (Boon et al., 2013). The effect of
endogenous, long-chain plasma ceramide on lipolysis are not known; however, culturing 3T3-L1
adipocytes with exogenous hydrophilic C2:0-ceramide can increase lipolysis by suppressing
insulin-stimulated activation of cyclic nucleotide phosphodiesterase 3B (Mei et al., 2002). The
inhibitory effect of ceramide on insulin signaling is ameliorated by treatments that decrease de
novo ceramide synthesis (e.g., reducing palmitic acid availability or pharmacological inhibition;
Mei et al., 2002; Holland et al., 2007; Ussher et al., 2010). Although the link between NEFA
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mobilization and metabolic disease has been extensively studied (Drackley and Andersen, 2006),
the relationship between circulating ceramides, lipolysis, and insulin sensitivity has not been
defined. Considering the recognized association between lipotoxicity-induced ceramide
accumulation in plasma and the development of insulin resistance in overweight monogastric
animals, we hypothesized that plasma ceramide concentrations would increase concomitantly with
NEFA availability and the decline in insulin sensitivity characteristic of the ruminant dairy cow
transitioning from late pregnancy to early lactation. We further hypothesized that overweight
peripartal cows would exhibit greater concentrations of ceramide in plasma and magnitude of
insulin resistance compared with lean cows. To test our hypotheses, we used liquid
chromatography coupled with mass spectrometry to perform a sphingolipidomic analysis of
plasma ceramides and glycosylated ceramides, an approach described by Merrill et al. (2009).

Materials and Methods

Experimental Design
Experimental procedures were approved by the West Virginia University Institutional
Animal Care and Use Committee (Morgantown). The experiment was completed at Dovan Farms,
WVU Agricultural Research and Education Partner, and a 700-Holstein cow commercial dairy
farm (located in Berlin, PA). Nonlactating, pregnant, multiparous Holstein cows (n = 21) were
enrolled in the study 45 d before expected parturition and allocated to 1 of 2 groups according to
their adiposity at d −30 relative to calving, as either lean (BCS 2.9 ± 0.22, n = 10) or overweight
(BCS 4.1 ± 0.10, n = 11). Parity was not different between BCS groups (P > 0.9), averaging 3.5 ±
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0.82 and 3.45 ± 1.08 for lean and overweight cows, respectively. Diets were formulated to meet
nutrient recommendations and cows were fed once and twice daily during pregnancy and lactation,
respectively. All diets were fed for ad libitum intake with free access to water. Ingredient and
nutrient compositions of the diets fed during the experiment are shown in Table 3-1. Samples of
TMR were obtained weekly throughout the experiment, and DM content was determined by drying
at 60°C until a static weight was observed. Weekly TMR samples were submitted to a commercial
laboratory for nutrient composition analysis by near-infrared spectroscopy (Cumberland Valley,
Cumberland, MD; AOAC International, 1995; method 989.03). Body weights and BCS were
recorded weekly. Three trained investigators independently recorded BCS for all cows and data
were averaged for each cow at d -45, -30, -15, -7, 4, 14, and 21 relative to expected parturition,
postpartum using a 1.0 to 5.0 scale (Wildman et al., 1982). Blood samples (10 mL) were collected
by coccygeal venipuncture at d -45, -30, -15, -7, and 4 relative to expected parturition. Blood was
kept on ice for 30 min until centrifugation at 3,400 × g for 10 min. Following centrifugation,
plasma was removed and snap-frozen in liquid nitrogen and then stored at −80°C until further
analysis. Milk production was recorded from d 2 to 21 postpartum. Milk samples were collected
at d 4 and 10 postpartum, preserved using Bronopol tablets (D&F Control Systems, San Ramon,
CA), and stored at 4°C for milk component analysis. Plasma samples were analyzed for glucose,
insulin, NEFA, BHBA, and ceramides. Plasma concentrations of glucose, NEFA, and BHBA were
determined by enzymatic methods using commercial kits (Autokit Glucose, HR Series NEFA-HR
(2) and Autokit 3-HB, respectively; Wako Chemicals USA Inc., Richmond, VA). Plasma
concentrations of insulin were determined by ELISA using a commercial product (Mercodia
Bovine Insulin ELISA; Mercodia AB, Uppsala, Sweden). All spectrophotometric measurements
were conducted using a SpectraMax Plus 384 Microplate Reader (Molecular Devices, Sunnyvale,
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CA). Intra- and interassay CV were 3.8 and 3.0%, 2.6 and 7.7%, 2.3 and 9.5%, and 3.7 and 16.6%,
for glucose, NEFA, BHBA, and insulin, respectively. Individual milk samples were analyzed for
fat, true protein, and lactose concentrations and SCC by mid-infrared spectroscopy (Dairy One,
Ithaca, NY; AOAC, 1990; method 972.160) within 1 wk of collection.

Ceramide Measurements
Plasma extraction was conducted using a modified Bligh and Dyer procedure including
ceramide C12:0 as an internal standard (Avanti Polar Lipids, Alabaster, AL; Haughey et al., 2004;
Bandaru et al., 2013). Plasma extracts were dried using a nitrogen evaporator and resuspended in
pure methanol for analysis. Sample extracts were handled using an autosampler (Leap
Technologies Inc., Carrboro, NC) that introduced extracts into an HPLC (PerkinElmer, Boston,
MA) with a C18 reverse-phase column (Phenomenex, Torrance, CA). Individual species of
ceramide were separated by gradient elution and injected into an electrospray ion source coupled
to a triple quadrupole mass spectrometer (API3000; AB Sciex Inc., Thornhill, ON, Canada;
Bandaru et al., 2007, 2011, 2013). Ion spray voltage was 5,500 V at a temperature of 80◦ C with a
nebulizer gas of 8 psi, curtain gas 8 psi, and collision gas 4 psi. Declustering potential was 80 V,
focusing potential 400 V, entrance potential 10 V, collision energy 30 V, and collision cell exit
potential 18 V. Individual ceramide species were detected by multiple reaction monitoring. Sixpoint calibration curves (0.1 to 750 ng/mL) were constructed by plotting the area under the curve
for each calibration standard, C16:0-, C18:0-, C20:0, C22:0-, and C24:0-ceramide, normalized to
C12:0- ceramide. Sphingolipid concentrations were determined by curve fitting the identified
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ceramide species based on acyl-chain length. Quantification of spectral data was performed using
Analyst 1.4.2 and MultiQuant software (AB Sciex Inc.).

Calculations and Statistical Analysis
Plasma glucose, insulin, NEFA, and BHBA concentrations were measured, and insulin
sensitivity was estimated using the revised quantitative insulin sensitivity check index (RQUICKI;
Holtenius and Holtenius, 2007), where RQUICKI = 1/[log (glucose) + log (insulin) + log (NEFA)],
and glucose = basal glucose (mg/dL), insulin = basal insulin (μU/mL), and NEFA = basal NEFA
(mmol/L), such that lower RQUICKI values suggest reduced whole-body insulin sensitivity, and
higher values are indicative of elevated whole-body insulin sensitivity. Changes in BCS and BW
of lean and overweight cows were calculated as the differences between values at d −21 and −7,
and the differences between d 4 and 21, relative to parturition. Somatic cell score was calculated
from SCC for statistical analysis, using the following logarithmic transformation (Ali and Shook,
1980), where SCS = Log2 (SCC/100,000) + 3. Changes in BCS and BW pre- and postpartum were
analyzed using the GLM procedure of SAS (version 9.3; SAS Institute Inc., Cary, NC). All data
for plasma and milk variables were analyzed as repeated measures over time relative to parturition
under the MIXED procedure of SAS (SAS Institute Inc.). The statistical model included the
random effect of cow nested within BCS and the fixed effects of BCS, day relative to parturition,
and their interaction. The most appropriate covariance structure for the repeated-measures analysis
was selected for each variable after evaluating 7 different covariance structures (variance
components, first-order autoregressive, heterogeneous first-order autoregressive, compound
symmetry, heterogeneous compound symmetry, first-order ante-dependence, and unstructured),
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and the structure with the smallest Akaike’s information criterion coefficient was selected for
analysis. Modeling of the covariance structure allowed the identification of patterns that best
describe relationships between the repeated measures in the model. The method of Kenward-Roger
was used for calculation of denominator degrees of freedom. Preplanned contrasts were used to
evaluate differences between lean and overweight cows at each time point. Relationships between
select ceramides were evaluated by random regression, using the MIXED procedure of SAS (SAS
Institute Inc.). The full model included the random effect of cow and the linear and quadratic
effects of each predictor. Quadratic effects were removed from the model based on fit by Akaike’s
information criterion scores when P > 0.05. Denominator degrees of freedom were calculated by
the Satterthwaite method. Studentized residual values >3.0 or < −3.0 were considered outliers and
removed from the analysis (typically 1 per response variable). Nonparametric Spearman rankorder correlations were performed to determine associations between plasma sphingolipids and
NEFA levels, and between sphingolipids and RQUICKI values. All results are expressed as least
squares means and their standard errors, unless stated otherwise. Significance was declared at P <
0.05 and trends at P < 0.10.

Results and Discussion
Overweight dairy cows transitioning from late pregnancy to early lactation will mobilize
more adipose to meet energy demands than lean cows (Rukkwamsuk et al., 1999). To validate this
response, BCS and BW were evaluated in lean and overweight transition cows (Figure 3-2). Cows
that were overweight experienced accelerated BCS loss (P < 0.01) and tended to lose more BW (P
= 0.10) during late pregnancy; however, no differences in the rate of BCS or BW loss were detected
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during lactation (data not shown). Milk yield increased during early lactation but was not affected
by BCS (29.4 ± 1.2, 37.5 ± 1.0, 39.3 ± 1.0 and 42.1 ± 1.1 kg/d, for 4, 10, 14 and 21 DIM,
respectively; P < 0.001). Although no change was observed for milk fat or lactose yield, a tendency
for a BCS × day relative to parturition interaction was found for increased milk protein yield in
overweight cows at 10 DIM (1.38 vs. 1.15 kg/d; P = 0.06). No significant response was detected
for SCS; however, overweight cows tended to have an elevated SCS at 10 DIM relative to lean
cows (2.27 vs. 1.86, respectively; P = 0.10)—a potential indicator of compromised mammary
gland immune function. In overweight humans, elevated plasma concentrations of glucose, insulin,
and NEFA are markers associated with the development of insulin resistance, hallmark
characteristics of type 2 diabetes (Reaven et al., 1988; Thévenod, 2008). Comparably, Holtenius
and Holtenius (2007) demonstrated a negative linear relationship between adiposity and RQUICKI
(i.e., cows with a high BCS have a low RQUICKI value), an observation supported by reduced
glucose disappearance following a glucose tolerance test in overweight cows (Holtenius et al.,
2003; Jaakson et al., 2013). For validation, we measured the plasma concentrations of glucose,
insulin, and NEFA, and calculated RQUICKI values for lean and overweight cows during the
transition from pregnancy to lactation (Figure 3-3). Compared with lean cows, plasma glucose
concentrations were greater in overweight animals at d -15 and -7 relative to parturition (P < 0.05).
Insulin concentrations were higher in overweight cows at d -30 and -15 (P < 0.01), and tended to
be greater at d 4 (P = 0.06). A progressive decline in plasma insulin concentrations was observed,
being 25 and 55% lower at d -7 and 4, respectively, relative to d -30 (P < 0.001). Plasma NEFA
concentrations increased by 30, 149, and 321% on d -15, -7 and 4, respectively, relative to d -30
(P < 0.001). As expected, overweight cows had higher NEFA concentrations at d -15 (P < 0.05),
and tended to be higher at d -7 and 4 relative to parturition (P = 0.06). The observed increase in
36

plasma NEFA and decrease in plasma insulin at the onset of lactation are characteristic
homeorhetic adaptations to maximize milk synthesis, responses linked with lower voluntary
energy intake (Drackley et al., 2005). These physiological changes were associated with lower
RQUICKI values postpartum (P < 0.001), indicative of reduced insulin sensitivity. Specifically,
RQUICKI decreased by 8, 15, and 14% on d -15, -7, and 4, respectively, relative to d -30 (P <
0.001). Compared with lean cows, insulin sensitivity was significantly lower at d -30, -15, -7 and
4 relative to parturition (P < 0.05). We also observed lower RQUICKI values in dairy cattle with
greater adiposity as early as d -45 (P = 0.07), a pathological response that preceded prepartum
elevations in plasma glucose, insulin, and NEFA. The observed reductions in prepartum insulin
sensitivity may relate to antagonism of adipose tissue insulin signal transduction by saturated fatty
acids in overweight cows (Boden, 1997), an action that could explain the observed acceleration in
adipose tissue NEFA mobilization. Plasma concentrations of BHBA were not affected by BCS;
however, BHBA was 40% higher at d 4 relative to d -30 (465 vs. 333 μmol/L, respectively; P <
0.01). The acyl chain specificity of 6 dihydroceramide synthases produces structurally diverse
sphingolipids (Park and Pewzner-Jung., 2013). To elucidate the structural diversity of ceramide
and glycosylated ceramide in dairy cows, we used liquid chromatography coupled with mass
spectrometry to separate 30 plasma species by acyl chain length including long-chain ceramides,
monohexosylceramides, and lactosylceramides, as well as a limited number of dihydro species
(Figure 3-4). Similar to humans and rodents (Ichi et al., 2006; Haus et al., 2009), C16:0- and
C24:0-ceramide were the most abundant plasma ceramides, representing 30 and 58% of total
ceramide, respectively, across lean and overweight cows. Similarly, C24:0-monohexosylceramide
and C16:0-lactosylceramide represented the major plasma monohexosylceramide and
lactosylceramide species, respectively. In humans, approximately 98% of plasma ceramides are
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found within liver-derived lipoprotein subfractions (i.e., high, low, and very low density
lipoproteins; Lightle et al., 2003; Boon et al., 2013); however, the origin of ceramides over time
and between BCS groups in this study is unknown and will require further definition. Measurement
of plasma ceramides can be a means to diagnose the severity of insulin resistance in humans
experiencing hyperlipidemia and nonalcoholic fatty liver disease (Haus et al., 2009). Therefore,
we compared the plasma ceramide and glycosylated ceramide profiles with the development of
insulin resistance in lean and overweight dairy cows (Figure 3-5). Plasma concentrations of total
ceramide increased as parturition approached (Figure 3-6); however, these responses were
accelerated in dairy cows exhibiting greater adiposity, NEFA mobilization, and magnitude of
insulin resistance. Of interest, plasma C24:0-ceramide, the most abundant ceramide in bovine
plasma, increased by 92% on d 4 relative to d −30 (P < 0.001; Figure 7), and tended to be greater
in overweight cows at d -7 (P = 0.09). Concentrations of C18:0-, C18:1-, C20:0-, C22:0, C22:1,
and C24:1-ceramide were also significantly greater in overweight cows during the peripartal
period (P < 0.05; Figure 3-10), relative to lean cows, and C26:0- and C26:1-ceramide
concentrations tended to be increased in overweight dairy cows on d 4 and d -15, respectively,
relative to d -30 (P = 0.06). In contrast, plasma C16:0-ceramide concentrations did not change
with time or score of adiposity (Figure 4-7). Because palmitic acid is a required substrate for de
novo synthesis of all sphingolipids including ceramides, glycosylated ceramides, and
sphingomyelins (i.e., palmitic acid is part of the sphingoid backbone), palmitic acid availability
may have been limited for C16:0-ceramide synthesis in overweight cows. De novo synthesis of
ceramide is contingent on the fatty acyl-CoA-dependent acylation of sphinganine to form
dihydroceramide, a reaction mediated by dihydroceramide synthase. We measured one
dihydroceramide in bovine plasma, C16:0-dihydroceramide (Figure 3-11). Plasma C16:038

dihydroceramide tended to be greater in overweight cows at d -15 (+47%; P = 0.07). The elevated
concentration of plasma C16:0-dihydroceramide is indicative of increased ceramide anabolism in
tissues of dairy cows transitioning from pregnancy to lactation. We also detected a significant
positive association between plasma C16:0-dihydroceramide and C16:0-ceramide across all
sampled cows (P < 0.001; Figure 12). The strong relationship between these sphingolipids may be
explained by enhanced activity of hepatic dihydroceramide desaturase in transition dairy cows;
however, additional research is needed to confirm this hypothesis. Glycosylated ceramides include
monohexosylceramides (e.g., glucosylceramide and galactosylceramide) and lactosylceramides,
glycosphingolipids synthesized from ceramide and precursors for monosialodihexosylganglioside
synthesis (GM3, a ganglioside; Figure 3-1). Similar to ceramide, monohexosylceramide levels are
elevated in plasma from obese, insulin-resistant rodents (Chavez et al., 2014). To determine
whether a similar relationship exists in overweight dairy cows, we profiled these plasma
glycosphingolipids (Figures 3-5, 3-6, and 3-7 and Figure 3-13 and Figure 3-14). Subsequent to the
prepartum increases in plasma ceramides, we detected an increase in the concentrations of most
plasma monohexosylceramides in overweight cows postpartum (Figure 5). These results were
expected because monohexosylceramide synthesis is contingent on ceramide availability (Figure
1). For example, as plasma NEFA and ceramide levels increased with time, the concentration of
C24:0-monohexosylceramide (the most hexosylceramide synthesis is contingent on ceramide
availability (Figure 3-1). For example, as plasma NEFA and ceramide levels increased with time,
the

concentration

of

C24:0-monohexosylceramide

(the

most

abundant

plasma

monohexosylceramide) increased (P < 0.001; Figure 3-7). Relative to adiposity, plasma C24:0monohexosylceramide was elevated in overweight cows at d 4 postpartum (BCS × day relative to
parturition, P < 0.01). Similar observations were seen for C24:0-lactosylceramide. Furthermore,
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we

observed

a

strong

positive

association

between

C24:0-ceramide

and

C24:0-

monohexosylceramide, and between C24:0- monohexosylceramide and C24:0-lactosylceramide
across all sampled cows (Figure 3-8). These results may indicate a coordinated regulation of
synthesis for these sphingolipids containing the C24:0 acyl moiety in tran sition dairy cow tissues.
In contrast to total ceramide and monohexosylceramide, total lactosylceramide concentrations
were not modified with enhanced adiposity (Figure 6); however, C16:0-lactosylceramide (the most
abundant plasma lactosylceramide) concentrations were lower in overweight cows compared with
lean cows (P < 0.01). Increased circulating NEFA can promote insulin resistance by promoting
ceramide accumulation in plasma and peripheral tissues of humans and rodents (Watt et al., 2012).
Considering that NEFA can induce insulin resistance in dairy cows (Pires et al., 2007a), we
hypothesized that plasma ceramide concentrations would increase concomitantly with NEFA
availability and the development of insulin resistance. To test this hypothesis, we performed a
Spearman correlation analysis to identify significant correlations between individual sphingolipid
species, and NEFA levels or RQUICKI values (Figure 3-9). As expected, NEFA correlated
negatively with insulin sensitivity (r = -0.62, P < 0.05). The majority of ceramides and
monohexosylceramides were positively correlated with NEFA concentrations and negatively
correlated with insulin sensitivity. Significant positive correlation coefficients between NEFA
levels and multiple ceramide species were detected, ranging from 0.23 to 0.60 (P < 0.05), with the
strongest correlations observed for C24:0-ceramide, total monohexosylceramide, and C22:0monohexosylceramide (P < 0.001). Significant negative correlation coefficients between
ceramides and RQUICKI values ranged from -0.33 to -0.22 (P < 0.05), and included total ceramide
as well as individual ceramide subspecies (i.e., 20:0, C22:0, C24:0, C24:1, and C26:0). A
remarkably similar relationship has been observed in obese type 2 diabetic patients and lean
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healthy control subjects (Haus et al., 2009). In further support, baseline measurements of C20:0-,
C24:0-, and C24:1-ceramide were inversely related to insulin sensitivity in overweight adults
(Dubé et al., 2011). In contrast, we did not detect significant correlations between plasma
glycosylated ceramides (i.e., monohexosylceramides or lactosylceramides) and estimated wholebody insulin sensitivity. Comparably, dihydroceramide and ceramide classes correlate with type 2
diabetes and prediabetes in humans, correlations not observed for monohexosylceramide or
lactosylceramide (Meikle et al., 2013). The development of insulin resistance and lipolysis
represent coordinated shifts in metabolism to support lactation. Reduced insulin stimulation during
the transition from gestation to lactation allows adipose tissue metabolism to change from
lipogenic to lipolytic (McNamara, 1991), a shift that facilitates hepatic NEFA processing
(Drackley et al., 2005). Although ceramides can be synthesized from NEFA and are known
effectors of insulin resistance in monogastrics, little is known of their involvement in the
homeorhetic process that modifies nutrient partitioning in cows transitioning from gestation to
lactation. Because our observed increases in plasma ceramide concentrations occurred
concomitantly with changes in NEFA, insulin, and insulin sensitivity in both lean and overweight
cows during the transition from gestation to lactation (Figure 3-3, Figure 3-6, and Figure 3-9), the
accumulation of ceramide may represent a homeorhetic adaptation that allows periparturient cows
to undergo these characteristic shifts in metabolism. Given that the mammalian sphingolipidome
comprises a vast array of complex lipids, a major challenge in the field of sphingolipid biology is
to identify which species are the primary effectors of insulin resistance in different tissues. A
limitation of the current study is that we did not evaluate ceramide metabolism or insulin signaling
in liver, skeletal muscle, or adipose tissue. Future studies will need to use rapidly advancing
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sphingolipidomics-based methodologies to address whether plasma or tissue ceramide can mediate
the development of insulin resistance in periparturient dairy cows.

Conclusion
Insulin resistance accelerates lipolysis and increases metabolic disease risk in periparturient dairy
cattle, and ceramide is an inhibitor of insulin action in monogastrics; however, the relationship
between plasma ceramide and insulin resistance has not been characterized in peripartal cows. We
conclude that ceramides accumulate in plasma during the progression of insulin resistance in
overweight cows transitioning from late pregnancy to early lactation. These data support the
potential involvement of ceramide in the pathological development of insulin resistance in dairy
cattle. We also conclude that changes in plasma ceramide abundance occur concomitantly with
changes in plasma NEFA, insulin, and insulin sensitivity, suggesting that circulating ceramides
may be fundamentally involved in the homeorhetic adaptation to early lactation. To evaluate these
possibilities, future work should focus on determining whether augmented insulin resistance in
overweight cows is caused by maladaptive changes in fatty acid processing that promote the
synthesis and accumulation of ceramide, and whether antagonism of insulin signaling is ceramide
dependent. Identifying the mechanisms of insulin resistance may reveal metabolic pathways that
can be manipulated to improve insulin sensitivity, reduce lipolysis, and improve cow health.
Researchers should also evaluate the efficacy of plasma ceramide subspecies as diagnostic
predictors for metabolic disease risk relative to the commonly utilized biomarkers NEFA and
BHBA.
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Table 3-1. Ingredients and nutrient composition of diets fed to lean and overweight cows during
the transition from late pregnancy to early lactation.
Diets
Ingredients, % of DM
Corn silage
Mixed grass haylage
Mixed grass hay
Dry ground corn
Prepartum mix1
Lactation mix A2
Aminoplus
Cottonseed with lint
Sugar cane syrup
Lactation mix B3
Close-up supplement4
Rumensin5

14.7
9.4
-

d -21 to
parturition
30.7
28.4
13.2
13.9
9.0
4.8
-

49.1
48
42.8
89.2
32
12.3
15
3.1
7.4

49
49
43.7
89.2
32.5
12.2
14.7
3.4
7.5

d -60 to -21
32.2
29.8
13.9

Lactation
42.4
7.0
2.1
14.4
14
4.7
4.5
3.6
4.5
2.7
0.1

Nutrient Composition
DM, %
NDF, % of DM
Forage NDF, % of DM
Forage NDF, % of NDF
ADF, % of DM
CP, % of DM
Starch, % of DM
Crude fat, % of DM
Ash, % of DM
1

47.4
33.4
25.1
75.3
21.4
16.5
24.8
4.4
7.6

Mix contained 27% commercial dry cow mix with Animate (Phibro Animal Health Corp., Teaneck, NJ),
17.3% ground corn, 17.3% crimped oats, 13% corn distillers, 12.9% soybean meal, 4.3% calcium
carbonate, 4.3% calcium sulfate, 2.6% Omnigen AF (Phibro Animal Health Corp.), 1.1 Monocalcium
phosphate, and < 1% of each of the following: Sel-plex 600 (Alltech Biotechnology, Nicholasville, KY)
and vitamin E. 2Mix contained 33.6% citrus pulp, 19% soybean meal. 15.6% canola meal, 14% soybean
hulls, 4.5% calcium carbonate, 4.5% sodium bicarbonate, 2.8% urea, 2.7% fat, 2.4% sodium chloride, and
<1% from each of the following: Monocalcium phosphate, biotin, and Rumensin 90 (Elanco Animal
Health, Greenfield, IN). 3Mix contained 43.6% Fermenten (Church and Dwight Co., Princeton, NJ),
21.8% calcium carbonate, 10.8% soybean hulls, 7.8% Mintrex blend (Novus International Inc., St.
Charles, MO), 5.2% blood meal, 3.5% magnesium oxide, 2.6% Celmanax (Vi-COR, Mason City, IA),
2.6% Omnigen (Phibro Animal Health Corp.), and <1% of each of the following: vitamin E, selenium
selenite, and selenium yeast 600. 4Mix contained 74.5% ground oats, 15.3% commercial amino acid, 8%
Reashure (Balchem Encapsulates, Slate Hill, NY), and <1% of each of the following: vitamin E and
Niashure (Balchem Corporation, New Hampton, NY). 5Rumensin for dairy included at 4,890 mg/kg.
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Figure 3-1. Metabolic pathways of ceramide synthesis.
Ceramide can be generated by three pathways: de novo synthesis initiated by the condensation of
palmitoyl-CoA and serine to form 3-ketosphinganine, hydrolysis of sphingomyelin, or breakdown
of complex sphingolipids via a series of reactions referred to as the salvage pathway. Complex
sphingolipids have various acyl chain lengths varying in carbon length and degree of saturation.
For simplicity, C16:0-linked sphingolipids and glycosphingolipids are illustrated.
Monohexosylceramides consist of a single sugar residue, either glucose or galactose
(galactosylceramide is not shown).
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Figure 3-2. Overweight dairy cows lost more prepartum body condition and weight, relative to
lean cows.
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Figure 3-3. Overweight dairy cows are insulin resistant before onset of lipolysis.
Plasma concentrations of (A) glucose, (B) insulin, and (C) NEFA, of lean and overweight dairy
cattle transitioning from late pregnancy to early lactation. (D) Estimated insulin sensitivity as
measured by the revised quantitative insulin sensitivity check (RQUICKI). RQUICKI was
calculated as follows: 1/[log(glucose) + log(insulin) + log(NEFA)]. Lower RQUICKI values are
indicative of reduced insulin sensitivity. Data are least squares means and their standard errors. *,
P < 0.05; +, P < 0.10.
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Figure 3-4. C16:0- and C24:0-ceramide are high-abundant ceramides in bovine plasma.
Plasma composition of (A) ceramides, (B) monohexosylceramides, and (C) lactosylceramides in
lean and overweight dairy cows transitioning from late pregnancy to early lactation (d -30 to 4,
relative to parturition). C16:0-dihydroceramide, C16:0-dihydro-monohexosylceramide, and
C16:0-dihydro-lactosylceramide are not included. Data presented as mean abundance ± SD.
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Figure 3-5. Plasma ceramides, monohexosylceramides, and lactosylceramides are elevated in
overweight dairy cows transitioning from gestation to lactation.
For visualization purposes, the heat map represents the magnitude of mean-centered, fold change
increases (red) or decreases (blue) for each sphingolipid or glycosphingolipid, relative to lean cows
sampled at d -30 prepartum. The heat map was generated using MetaboAnalyst 2.0 (Xia et al.,
2012).
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Figure 3-6. Plasma concentration (ng/mL) of total ceramides, monohexosylceramides, and
lactosylceramides in lean and overweight cows transitioning from late pregnancy to early lactation,
relative to lean cows.
Plasma concentration of total (A) ceramide, (B) monohexosylceramide, and (C) lactosylceramide
in lean and overweight peripartal dairy cows. Data are represented as least squares means and their
standard errors. *, P < 0.05; +, P < 0.10.
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Figure 3-7. Plasma concentration (ng/mL) of C24:0-linked ceramide, monohexosylceramide, and
lactosylceramide is elevated in overweight cows transitioning from late pregnancy to early
lactation, relative to lean cows.
Plasma concentration of (A) C16:0-ceramide, (B) C24:0-ceramide, (C) C16:0monohexosylceramides, (D) C24:0-monohexosylceramide, (E) C16:0-lactosylceramide, and (F)
C24:0-lactosylceramide in lean and overweight transition dairy cows. Data are represented as least
squares means and their standard errors. *, P < 0.05; +, P < 0.10.
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Figure 3-8. Plasma C24:0-ceramide is positively associated with C24:0-monohexosylceramide,
and C24:0-monohexosylceramide is positively associated with C24:0-lactosylceramide.
Random regression analysis between plasma concentrations of (A) C24:0-ceramide and C24:0monohexosylceramide and (B) C24:0-monohexosylceramide and C24:0-lactosylceramide in lean
and overweight dairy cows during the transition from late pregnancy to early lactation. R2
coefficients represent the association between observed and model predicted values when
accounting for the random effect of cow. Data represents measurements for d -30, -15, -7, and 4,
relative to parturition.
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Figure 3-9. Plasma ceramides are positively correlated with circulating NEFA, and negatively
correlated with insulin sensitivity in dairy cows transitioning from late pregnancy to lactation.
Non-parametric Spearman’s rank-order correlations of circulating ceramides to (A) plasma NEFA
and (B) revised quantitative insulin sensitivity check (RQUICKI). RQUICKI was calculated as
follows: 1/[log(glucose) + log(insulin) + log(NEFA)]. Lower RQUICKI values are indicative of
reduced insulin sensitivity. ***, P < 0.001; **, P < 0.01; *, P < 0.05; +, P < 0.10.
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Figure 3-10. Supplemental 3-1. Plasma concentrations (ng/mL) of low-abundant ceramides in lean
and overweight cows transitioning from late pregnancy to early lactation, relative to lean cows.
Plasma concentrations of (A) C16:1-, (B) C18:0-, (C) C18:1-, (D) C20:0-, (E) C22:0-, (F)
C22:1-, (G) C24:1, (H) C26:0-, and (I) C26:1-ceramide in lean and overweight transition dairy
cows. Data are represented as least squares means and their standard errors. *, P < 0.05; +, P <
0.10.
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Figure 3-11. Supplemental 3-2. Plasma concentrations (ng/mL) of C16:0-linked dihydroceramide,
dihydro-monohexosylceramide, and dihydro-lactosylceramide in lean and overweight cows
transitioning from late pregnancy to early lactation, relative to lean cows.
Plasma concentrations of C16:0-linked (A) dihydroceramide, (B) dihydro-monohexosylceramide,
and (C) dihydro-lactosylceramide in lean and overweight transition dairy cows. Data are
represented as least squares means and their standard errors. *, P < 0.05; +, P < 0.10.
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Figure 3-12. Supplemental 3-3. Plasma C16:0-dihydroceramide is positively correlated with
C16:0-ceramide.
Simple linear regression analysis between plasma concentrations of C16:0-dihydroceramide and
C16:0-ceramide in lean and overweight dairy cows during the transition from late pregnancy to
early lactation. Data represents measurements for d -30, -15, -7, and 4, relative to parturition.
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Figure 3-13. Supplemental 3-4. Plasma concentrations (ng/mL) of low-abundant
monohexosylceramides in lean and overweight cows transitioning from late pregnancy to early
lactation, relative to lean cows.
Plasma concentrations of (A) C16:1-, (B) C18:0-, (C) C18:1-, (D) C20:0-, (E) C22:0-, (F) C22:1, (G) C24:1, and (H) C26:0-monohexosylceramide in lean and overweight transition dairy cows.
Data are represented as least squares means and their standard errors. *, P < 0.05; +, P < 0.10.
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Figure 3-14. Supplemental 3-5. Plasma concentrations (ng/mL) of low-abundant
lactosylceramides in lean and overweight cows transitioning from late pregnancy to early lactation,
relative to lean cows.
Plasma concentrations of (A) C18:0-, (B) C18:1-, (C) C22:0-, and (D) C24:1-lactosylceramide in
lean and overweight transition dairy cows. Data are represented as least squares means and their
standard errors. *, P < 0.05; +, P < 0.10.
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Chapter 4
TEMPORAL CHANGES IN CIRCULATING AND TISSUE SPHINGOLIPIDS DURING
THE TRANSITION FROM GESTATION TO LACTATION.

Abstract
Insulin is fundamentally involved in the homeorhetic adaptations that accompany late
gestation and early lactation in dairy cows. Insulin resistance develops naturally during the
peripartal period and is associated with increased lipolysis in adipose tissue, as well as hepatic fat
accumulation. Increased fatty acid availability favors accumulation of the sphingolipid ceramide
in monogastrics and in peripartal dairy cows. Ceramide is associated with the pathogenesis of
insulin resistance in obese models of type 2 diabetes and humans with metabolic disease. In
addition, limited evidence suggests that ceramides may be involved in processes that facilitate
labor in humans, thus supporting a physiological roles for ceramide during perpartum. Despite this
evidence, the relationship between sphingolipids and insulin action during the transition from
gestation to lactation is currently unknown. Therefore, our objectives were to characterize
temporal responses in plasma and tissue sphingolipids during peripartum, and to determine
whether these changes were related to adiposity, lipolysis, and insulin action. Multiparous Holstein
cows were grouped by adiposity score (BCS) at d-28 prepartum as either lean (BCS 2.9 ±0.13; n
=7) or overweight (BCS 4.0 ±0.21; n =7). Blood samples were collected routinely from d-21 to
21, relative to calving, and liver and skeletal muscle biopsies were obtained at d-21, -7, and 4,
relative to parturition. Liquid chromatography and tandem mass spectrometry was utilized to
profile

ceramides,

monohexosylceramides

(GlcCer),

lactosylceramides

(LacCer),

and

sphingomyelins with variable acyl-chain lengths and degree of saturation. Plasma C16:0-ceramide
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concentration was higher in overweight cows prepartum and decreased significantly during
postpartum, in association with increased C16:0-GlcCer. C24:0-ceramide, the most abundant
ceramide in plasma, increased by 50% across the transition period and was higher in overweight
during postpartum. Moreover, C24:0-ceramide in plasma was positively associated with hepatic
fat accumulation. Glycosylated ceramides in plasma increased postpartum, but were not affected
by adiposity. Plasma sphingomyelin, a source of ceramides, decreased toward parturition and
increased postpartum. Sphingomyelins were lower in the plasma of overweight cows during the
peripartal period. Hepatic C24:0-Cer was the most abundant ceramide in the liver, and its
concentration increased postpartum and was positively associated with plasma C24:0 ceramides.
Several hepatic ceramides and glycosylated ceramides were higher in overweight cows during
postpartum. Muscle ceramide, on the other hand, was higher in lean cows prepartum, and increased
in overweight cows during the transition from gestation to lactation. Plasma ceramides were
positively associated with plasma NEFA and inversely associated with glucose disappearance
during an insulin challenge. Moreover, glycosylated ceramides were inversely associated with
reduced insulin secretion. Our results demonstrate that plasma and tissue sphingolipids change
dynamically during the transition from gestation to lactation, and are associated with the onset of
peripartal insulin resistance. These observations are in line with a possible role for certain
ceramides in facilitating the physiological adaptations of peripartum. Future research should focus
on directly evaluating these possibilities.
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Introduction
Major physiological adaptations accompany late pregnancy and early lactation in dairy
cows, which allow uninterrupted nutrient supply to the fetus (prenatally) and to the newborn calf
(postnatally). During the last trimester of lactation, the growth of the conceptus (fetus and fetal
membranes) follows an exponential curve, driving increased demands for energy (glucose) and
protein for the gravid uterus (Eley et al., 1978, Bell et al., 1995; NRC, 2001). Deposition of fat,
protein, and glycogen account for most of the energy content of fetal tissues during late pregnancy
(Bell et al., 1995). Once lactation is initiated, the synthesis of milk and its components typically
results in a doubling of daily energy requirements in modern, high-producing dairy cows (Drackley
et al., 2005). Moreover, increased glucose flux toward the mammary gland favors lactose synthesis
and results in a 3-4 fold increased in daily glucose requirements (Bell, 1997). In order to cope with
these localized nutrient demands, tight regulation of metabolism is required during the transition
from gestation to lactation. The control of metabolism during this period involves homeostatic as
well as homeorhetic regulation (Bauman and Currie, 1980). In particular, homeorhetic control
allows coordinated shifts in metabolism in tissues such as the adipose tissue, skeletal muscle, liver,
and the mammary gland. Metabolic changes that facilitate increased glucose partitioning toward
the fetus and the mammary gland include a progressive reduction of insulin secretion and
responsiveness, (Bell, 1995; Bell and Bauman, 1997), as well as circulating endocrine regulators,
such as growth hormone, estrogens, and progesterone, among others (Tucker, 1985). As a result,
dairy cows experience increased lipolysis (McNamara, 1991), hepatic ketogenesis and
gluconeogenesis, thus increasing glucose flux into the mammary gland (Bell, 1995, Spachmann et
al., 2013).
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The development of insulin resistance in associated with the accumulation of ceramide in
models of obesity and insulin resistance (Summers et al., 1998; Haus et al., 2009). Ceramides are
anti-anabolic sphingolipids with key regulatory functions such as control of cell cycles, cell death,
and response to stress (Hannun and Obeid, 2008). Although they are diverse chemical entities, all
ceramides are composed of a sphingoid backbone which is acylated with many possible fatty acid
residues (Gault et al., 2010; Chen et al. 2010) differing in chain length and degree of saturation,
by the activity of several ceramide synthases (i.e. C2-C26; Levy and Futerman, 2010). Two major
pathways contributing to ceramide accumulation in cells are de novo ceramide synthesis and
sphingomyelin hydrolysis (Figure 5-1). De novo ceramide synthesis uses palmitoyl CoA and
serine to produce ceramides (Holland and Summers, 2008), and the flux through this pathway is
strongly influenced by saturated fatty acid (SFA) availability and inflammatory signals, such as
TNFα and IL-6 (Merrill, 2002; Samad et al., 2006; Senn, 2006). Sphingomyelins are highly
abundant sphingolipids in plasma membranes, and consist of a phosphorylcholine ester-bound to
ceramide. The hydrolysis of sphingomyelin can generate ceramide in a reaction catalyzed by
sphingomyelinase (SMase) enzymes, which differ in their optimal pH and cellular locations
(Deigner et al., 2009; Boulgaropoulos, et al., 2010; Figure 5-1). This pathway is commonly
upregulated in obesity via the activation of inflammatory signals, which promote increased levels
of SMase (Samad et al., 2006).
Ceramides are commonly associated with excessive body fat and human type 2 diabetes,
and constitute a key causative link between circulating SFA availability and insulin resistance
(Chavez et al., 2003). Moreover, ceramides accumulate in insulin resistant tissues of rodents
(Summers, 2006; Holland and Summers 2008) and humans (Adams et al., 2004; Straczkowski,
2007). Using a dairy cow model, we have recently demonstrated that ceramides accumulate during
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late pregnancy and the first week of lactation in lean and overweight dairy cows (Rico et al., 2015).
Moreover, changes in plasma ceramide were associated with circulating NEFA availability,
suggesting that ceramide synthesis through de novo pathway may occur during peripartum,
particularly in overweight cows experiencing increased lipolysis. Along the same lines, because
the peripartal period is characterized by a state of inflammation (Sordillo and Raphael, 2013),
ceramide supply from sphingomyelin could be upregulated during this period. Although many cell
types have the capacity synthesize ceramides (Levy and Futerman, 2010), the liver is considered
to be the primary source of circulating ceramides (Watt et al., 2012). This supported by the
observation that the vast majority of plasma ceramides are found in association with the liverderived low- and very low-density lipoproteins (LDL and VLDL, respectively), fractions in which
C24:0-ceramide represents the major ceramide (Weisner et al., 2009). In view of these
observations, and considering that the peripartal increase in NEFA typically results in hepatic fat
accumulation in dairy cows, we hypothesized that hepatic ceramide content would be elevated
during the transition from gestation to lactation. Similarly, considering that the skeletal muscle is
responsible for most of the insulin-stimulated whole body glucose uptake in dairy cows
(Duhlmeier et al., 2015), and given that ceramide accumulation is commonly observed in skeletal
muscle of models of insulin resistance and obesity (Lipina and Hundal, 2011; DeFronzo, 2004;
Boon et al., 2013), we were interested in determining ceramide accumulation in skeletal muscle
of periparturient dairy cows. We further hypothesized that overweight peripartal cows would
exhibit greater concentrations of ceramide in plasma, liver and muscle, and that ceramide
accumulation would be associated with insulin resistance. To test our hypotheses, we used a
lipidomics approach, which employed liquid chromatography coupled with mass spectrometry,
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and characterized ceramides, glycosylated ceramides, and sphingomyelins in dairy cows
transitioning from gestation to lactation.

Materials and Methods

Experimental Design
Experimental procedures were approved by the West Virginia University Institutional
Animal Care and Use Committee (Morgantown). The experiment was completed at Dovan Farms,
WVU Agricultural Research and Education Partner, and a 700-Holstein cow commercial dairy
farm (located in Berlin, PA). Nonlactating, pregnant, multiparous Holstein cows (n = 14) were
enrolled in the study 30 d before expected parturition and allocated to 1 of 2 groups according to
their adiposity, as either lean (BCS 2.91 ± 0.13, n = 7) or overweight (BCS 4.0 ± 0.21, n = 7).
Cows were housed in a free-stall barn and trained to access feed by using Calan gate feeders
(American Calan, Inc., Norwood, NH). Diets were formulated to meet nutrient recommendations
and cows were fed once and twice daily during pregnancy and lactation, respectively. Cows were
fed at 110% of expected intake, adjusted daily, and provided free access to water. Ingredient and
nutrient compositions of the diets fed during the experiment are shown in Table 4-1. Samples of
TMR were obtained weekly throughout the experiment, and DM content was determined by drying
at 60°C until a static weight was observed. Body weights and BCS were recorded weekly. Three
trained investigators independently recorded BCS for all cows and data were averaged for each
cow at d -30 -21, -14, -7, relative to expected parturition, and d 0, 7, 14, and 21 postpartum, using
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a 1.0 to 5.0 scale (Wildman et al., 1982). Blood samples (10 mL) were collected by coccygeal
venipuncture at, -30, -21, -7, and -5, relative to expected parturition, and 0, 2, 4, 7, 14, and 21
postpartum. Blood was kept on ice for 30 min until centrifugation at 3,400 × g for 10 min.
Following centrifugation, plasma was removed and snap-frozen in liquid nitrogen and then stored
at -80°C until further analysis. Milk production was recorded from d 2 to 21 postpartum. Milk
samples were collected at d 2, 3, 4, 5, 6 and 7 postpartum, preserved using Bronopol tablets (D&F
Control Systems, San Ramon, CA), and stored at 4°C for milk component analysis.

Tissue Biopsies
Liver, and skeletal muscle biopsies were performed on d -21, -7 and 4 relative to the
parturition using aseptic techniques. For tissue biopsies, cows were anesthetized with xylazine
(0.04 mL/kg of BW) delivered via the coccygeal vein. After the hair was clipped, biopsy sites were
sanitized with iodine scrub and anesthetized with a 5 mL of lidocaine HCl (Vedco Inc., Saint
Joseph, MO) delivered subcutaneously. For liver biopsies, the 11th intercostal space was prepared
by making a 0.5 cm incision through the skin, and a fabricated trocar was utilized to collect
approximately 1 g of liver tissue (Hughes, 1962). Skeletal muscle biopsies were performed by
making a 0.5 cm incision in the skin adjacent to the semitendinosus muscle. Approximately 500
mg of muscle was collected using a Bard Magnum biopsy instrument mounted with a 12 gauge
needle (Bard Biopsy Systems, Tempe, AZ). Following the collection of tissue, biopsy sites were
stapled and sprayed with antiseptic, and Excenel RTU was delivered once by intramuscular
injection (0.68 mL/, kg of BW; Zoetis, Florham Park, NJ). Tissue for ceramide profiling was snapfrozen in liquid nitrogen and stored at -80°C. Tissue for PCR analysis was stabilized using
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RNAlater (Thermo Fisher Scientific Inc, Waltham, MA), refrigerated at 4°C during 24 h, and
stored at -20°C until RNA isolation was performed.

Insulin Tolerance Tests
Insulin tolerance tests (ITT) were performed on d -20, -6 and 5, relative to parturition using
previously described methods (Pires et al., 2007a). Briefly, a jugular catheter was inserted 24 h
prior to the ITT, and patency was maintained by flushing with heparinized saline every 12 h.
Access to feed was blocked 2h prior to ITT start. Cows were intravenously infused with 0.1IU of
insulin (100 IU/mL; human insulin rDNA origin; Eli Lilly Co., Indianapolis, IN) per kg of BW,
and followed by a 10-mL saline solution flush. Blood samples (10 mL) were collected at -10, 0,
10, 20, 30, 40, 60, 90, 120, 150, and 180 min relative to insulin infusion. Blood was processed as
described above. Feed was provided immediately following the completion of the ITT. The area
under the curve for glucose during ITT was calculated using the trapezoidal method as previously
described by others (Pires et al., 2007a).

Sample Analyses
Individually composited feed ingredients were analyzed for NDF with heat-stable αamylase and sodium sulfite (Van Soest et al., 1991), CP (AOAC International, 2000; method
990.03), and starch (Hall, 2009) by Cumberland Valley Analytical Services Inc. (Cumberland,
MD).
Plasma samples were analyzed for glucose, insulin, NEFA, BHBA, and ceramides. Plasma
concentrations of glucose, NEFA, and BHBA were determined by enzymatic methods using
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commercial kits (Autokit Glucose, HR Series NEFA-HR (2) and Autokit 3-HB, respectively;
Wako Chemicals USA Inc., Richmond, VA). Plasma concentrations of insulin were determined
by ELISA using a commercial product (Mercodia Bovine Insulin ELISA; Mercodia AB, Uppsala,
Sweden). All spectrophotometric measurements were conducted using a SpectraMax Plus 384
Microplate Reader (Molecular Devices, Sunnyvale, CA). Individual milk samples were analyzed
for fat, true protein, and lactose concentrations by mid-infrared spectroscopy (Dairy One, Ithaca,
NY; AOAC, 1990; method 972.160) within 1 wk of collection. Hepatic liver lipid was extracted
and quantified using the methodology described by Starke and collaborators (2010).
Ceramide extraction was conducted using previously established methods that employ a
modified Bligh and Dyer procedure including ceramide C12:0 as an internal standard (Avanti Polar
Lipids, Alabaster, AL; Haughey, et al., 2004; Bandaru et al., 2013; Rico et al., 2015). Briefly,
extracts were dried using a nitrogen evaporator and re-suspended in pure methanol for analysis.
Sample extracts were handled using an autosampler (LEAP technologies Inc., Carrboro, NC) that
introduced extracts into an HPLC (PerkinElmer, Boston, MA) with a C18 reverse-phase column
(Phenomenex, Torrance, CA). Individual species of ceramide were separated by gradient elution
and injected into an electrospray ion source coupled to a triple quadrupole mass spectrometer
(API3000; AB Sciex Inc., Thornhill, Ontario, Canada; (Bandaru et al., 2007; Bandaru et al., 2011;
Bandaru, 2013). Ion spray voltage was 5500 V at a temperature of 80◦C with a nebulizer gas of 8
psi, curtain gas 8 psi, and collision gas 4 psi. Declustering potential was 80 V, focusing potential
400 V, entrance potential 10 V, collision energy 30 V, and collision cell exit potential 18 V.
Individual ceramide species were detected by multiple reaction monitoring. Six point calibration
curves (0.1 to 750 ng/ml) were constructed by plotting area under the curve for each calibration
standard, C16:0-, C18:0-, C20:0-, C22:0-, and C24:0-ceramide, normalized to C12:0-ceramide.
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Sphingolipid concentrations were determined by curve fitting the identified ceramide species
based on acyl-chain length. Quantification of spectral data was performed using Analyst 1.4.2 and
MultiQuant software (AB Sciex Inc., Thornhill, Ontario, Canada).

Calculations and Statistical Analysis
Plasma glucose, insulin, NEFA, and BHBA concentrations were measured. Changes in
BCS and BW of lean and overweight cows were calculated as the differences between values at d
-21 and 21, relative to parturition, and were analyzed using the GLM procedure of SAS (version
9.3; SAS Institute Inc., Cary, NC). All data for time-dependent changes in plasma, tissue and milk
variables were analyzed as repeated measures over time relative to parturition under the MIXED
procedure of SAS (SAS Institute Inc.). The statistical model included the random effect of cow
nested within BCS and the fixed effects of BCS, day relative to parturition, and their interaction.
The covariance structure was modeled to identify patterns that best describe relationships between
the repeated measures. The most appropriate covariance structure was selected for each response
variable after evaluating 3 different covariance structures (variance components, first-order
autoregressive, heterogeneous first-order autoregressive, compound symmetry), and the structure
with the smallest Akaike’s information criterion coefficient was selected for analysis. The method
of Kenward-Roger was used for calculation of denominator degrees of freedom. Preplanned
contrasts were used to evaluate differences between lean and overweight cows at each time point.
Relationships between select ceramides were evaluated by random regression, using the MIXED
procedure of SAS (SAS Institute Inc.). The full model included the random effect of cow and the
linear and quadratic effects of each predictor. Quadratic effects were removed from the model
67

based on fit by Akaike’s information criterion scores when P > 0.05. Denominator degrees of
freedom were calculated by the Satterthwaite method. Studentized residual values >3.0 or < -3.0
were considered outliers and removed from the analysis (typically 1 per response variable).
Parametric pearson correlations were performed to determine associations between plasma
sphingolipids, NEFA levels, and glucose disposal, and between plasma and hepatic ceramides. All
results are expressed as least squares means and their standard errors, unless stated otherwise.
Significance was declared at P < 0.05 and tendencies at P < 0.10.

Results and Discussion
Ceramides of hepatic origin have the ability to disrupt insulin signaling, and accumulate in
plasma from type 2 diabetic and obesity animal models, as well as in overweight dairy cows
transitioning from gestation to lactation (Haus et al., 2009; Watt et al., 2012; Rico et al., 2015).
Moreover, ceramides accumulate around parturition in healthy humans and healthy dairy cows
(Signorelli et al., 2016; Rico et al., 2015), suggesting they may fulfil metabolic roles independently
of body fat accumulation. Two major pathways contributing to ceramide accumulation include de
novo synthesis and sphingomyelin hydrolysis, processes upregulated in association with increased
NEFA availability and peripartal inflammation (Watt et al., 2012; Peraldi et al., 1996; Signorelli
et al., 2016; Figure 4-1). Therefore, we evaluated the temporal changes in sphingolipids in plasma,
liver and skeletal muscle in lean and overweight cows transitioning from gestation to lactation (d
-21 to 21 relative to parturition). Because adipose tissue lipolysis increases during peripartum, and
can contribute to ceramide synthesis and insulin resistance, we evaluated the associations between
circulating NEFA, sphingolipids and insulin action. In order to measure changes in circulating and
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tissue ceramide levels, we employed liquid chromatography coupled with mass spectrometry to
perform a sphingolipidomic analysis of plasma ceramides, glycosylated ceramides, and
sphingomyelins This approach, described by Merrill et al. (2009), was utilized previously by our
research group (Rico et al., 2015), and allowed us to quantify 37 different ceramides, GlcCer,
LacCer, and sphingomyelins with differing acyl chain length and degree of saturation in plasma,
liver and skeletal muscle.
Detailed production and metabolic responses will be described briefly (unpublished data).
Compared with lean, overweight cows exhibited decreased appetite, increased body weight loss
and body fat loss, and had elevated fat accumulation in the liver during the peripartal period.
Although no differences in milk yield were detected, overweight cows had increased milk fat
content and secretion, a consequence of increased lipomobilization. Overweight cows displayed
increased plasma NEFA and BHBA during peripartum, and were hyperinsulinemic relative to lean
cows prepartum. Insulin concentration decreased gradually as parturition approached, and the rate
of glucose disposal in response to insulin challenge decreased postpartum, indicating reduced
insulin sensitivity after parturition.
Dynamic changes were observed in the concentrations of circulating ceramides and
glycosylated ceramides during peripartum (Figure 4-2; Figure 4-3). Most notably, glycosylated
ceramides increased around parturition, and were 35% and 53% higher in average for GlcCer and
LacCer during postpartum (P < 0.001). As expected, NEFA correlated positively with ceramides,
GlcCer and LacCer, (r = 0.22, 0.5 and 0.49, respectively; P < 0.05), consistent with an increase in
substrate flux in the de novo ceramide synthesis pathway. Although no temporal changes were
observed for total ceramide, individually, plasma ceramides displayed different patterns of change
across time during transition (Figure 4-4). For example, C16:0-ceramide, one the major ceramides
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found in plasma (Rico et al., 2016), decreased sharply by d 2, relative to d 0 (-32%, P < 0.05), and
remained low during postpartum. In contrast, C18:0-ceramide increased acutely around
parturition, peaking at d 0 (+40%, relative to prepartum), and decreased gradually over the 3 wk
period postpartum. The diversity of patterns in the changes of plasma ceramide, in addition to the
stability in the predominant C24:0-ceramide, explain the lack of time associated effects for total
ceramides, and suggest that peripartal ceramide metabolism is acyl-chain specific. In validation of
our previous investigation of ceramide metabolism during peripartum (Rico et al., 2015), several
plasma ceramides were elevated in overweight cows pre- and postpartum (i.e. C16:0-, C18:0-,
C22:0-, C24:0- and C26:0-ceramide; Figure 4-4).
Following a similar trend to that of total GlcCer, most plasma GlcCer increased around
parturition and remained elevated postpartum (C16:0-, C18:1-, C20:0-, C22:0-, and C24:0; P <
0.001, Figure 4-5). Overall, plasma GlcCer tended to be elevated in overweight cows, and were
significantly higher postpartum for some low-abundant GlcCer (e.g. 16:1- and C22:0-GlcCer).
Interestingly, an inverse relationship between C16:0-GlcCer and C16:0-ceramide was observed (r
= 0.4; P < 0.001). In our previous examination of plasma ceramides (Rico et al., 2015), C16:0ceramide was the only major ceramide to decrease postpartum, and observation validated by our
current data. Because glucosyceramide synthase is responsible for ceramide glycosylation
(Bleicher and Cabot, 2002), glucosylceramide can modulate ceramide metabolism and reduce its
availability for use in other cellular processes (Liu et al., 2013). Although acyl chain specificity
has not been demonstrated for glucosylceramide synthase, a preference for the highly abundant
C16:0-ceramide could significantly affect the plasma ceramide pool. From these observations, it
is possible that active glycosylation of C16:0-ceramide is responsible for a reduction in its
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availability during postpartum. Similarly, increased glycosylation of other ceramides could explain
their accumulation around parturition and during postpartum.
Plasma LacCer were consistently elevated postpartum (P < 0.01; Figure 4-6). For example,
C16:0-LacCer, the major plasma lactosylceramide, was 44% higher during postpartum, and
remained elevated during this period (P < 0.001). In addition, most plasma LacCer detected were
higher in overweight cows during postpartum (i.e. C18:0, C22:0-, C24:0-, C24:1-lacCer; P < 0.01).
Because the effects of LacCer on insulin signaling have yet not been established, the significance
of these changes cannot be asserted. However, it should be noted that LacCer represented 53% of
the total plasma ceramides, followed by simple ceramides (26%) and Glccer (20.8%). Because
lactosylceramides are precursors of gangliosides GM3 (Chavez et al., 2014), their increased
accumulation has the potential to impact cellular metabolism.
Similar to the profile of circulating sphingomyelins in adult humans (Hanamatsu et al.,
2014), C16:0-sphingomyelin was the predominant plasma sphingomyelin found in the peripartal
period, representing nearly 35% of total circulating sphingomyelin, and followed by C18:1-,
C20:1-, C24:1, and saturated-chain sphingomyelin (Figure 4-7). Total plasma sphingomyelin
decreased gradually toward parturition and was 30% lower at d 0, relative to d -21 (P < 0.001).
Similarly, the concentration of all circulating sphingomyelins and dihydro-sphingomyelins
decreased toward parturition and recovered to initial levels by wk 3 postpartum (Figure 4-8; Figure
4-9; Figure 4-15). This consistent pattern of change is suggestive of extensive sphingomyelin
degradation, which reaches a maximum at parturition. In addition, several plasma sphingomyelin
were consistently lower in overweight cows during the transition from gestation to lactation (e.g.
C16:1-, and the abundant C18:1- and C20:1-sphingomyelin), indicating that sphingomyelin
hydrolysis can contribute to ceramide accumulation during the entirety of the transition in
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overweight cows. Because ceramides can be produced by sphingomyelin degradation, we
hypothesize that a mechanism to facilitate ceramide accrual at parturition is responsible for the
observed reduction in sphingomyelin concentrations. This would be consistent with the recent
observation by Signorelli and collaborators (2015) that ceramide accumulates in placental tissue
of humans at parturition, driving inflammatory responses to reduce the duration of labor.
Inflammation is also a common physiological response observed in dairy cows close to calving
(Sordillo and Raphael, 2013), and it is known to drive sphingomyelin hydrolysis through the action
of inflammatory cytokines (Yang et al., 1993; Kolesnick and Golde, 1994; Peraldi et al., 1996).
Although it is possible that ceramide accumulation in tissues serves a similar purpose in
periparturent dairy cows, it could also facilitate other physiological responses around parturition
as it accumulates in different tissues. Although the overall relationship between plasma ceramides
and sphingomyelin was positive, the correlation coefficient was moderately low (r = 0.25; P <
0.05), the association between individual plasma ceramides and sphingomyelin was equivocal.
While the major plasma ceramide, C24:0, was positively associated with total sphingomyelin (r =
0.34; P < 0.01), other ceramides were inversely related to sphingomyelin. For example, plasma
C18:0-ceramide concentration was negatively associated with sphingomyelin, and had the
strongest correlation coefficient of all plasma ceramides (r = -0.6; P < 0.001). Moreover, changes
in C18:0- and C18:1-ceramide showed a moderately high association with C18:0-sphingomyelin
(r = -0.47 and -0.58, respectively; P < 0.001), indicating a substrate to product relationship within
acyl chain length. This is supported by the observation that the peripartal increase in C18:0ceramide was mirrored by an inverse decrease in the concentration of plasma sphignomyelin
(Figure 4-4 and Figure 4-9). The potential importance of the sphingomyelin hydrolysis pathway
to provide ceramide is highlighted by the observation that sphingomyelin comprises the great
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majority of the sphingolipids we measured in plasma. On average, plasma sphingomyelin was
2600-fold higher than plasma ceramides and 680-fold higher than all ceramides and glycosylated
ceramides combined. This suggest that even small changes in the concentration of sphingomyelin
could greatly affect ceramide accumulation.
Because the development of insulin resistance is associated with the accumulation of
ceramides in insulin tissues such as liver and skeletal muscle, and results in the disruption of insulin
signal transduction associated with the pathogensis of type 2 diabetes (Lipina and Hundal, 2011;
DeFronzo, 2004; Boon et al., 2013), we measured the ceramide content of liver and skeletal
muscle. The liver is considered the main source of plasma ceramides, as evidenced by the fact that
75% to 98% of total plasma ceramides are found contained within the apoB-containing low-, and
very low-density lipoproteins (LDL and VLDL; Weisner et al., 2009; Iqbal et al., 2015), as well
as in high density lipoproteins (HDL; Lightle et al., 2003; Boon et al., 2013). Similar to the profile
of plasma ceramides we have previously reported in peripartal dairy cows (Rico et al., 2015), we
observed that C24:0-ceramide and C24:0-Glccer and C16:0-Laccer were the major ceramides
found in hepatic tissue and skeletal muscle of hyperlipidemic, insulin resistant cows at d4
posptpartum (Figure 4-10; Figure 4-14). Specifically, C24:0-ceramide represented 70% and 65%
of total ceramides in liver and skeletal muscle, respectively. The importance of C24:0 ceramide
accumulation is highlighted by the findings of Boon and collaborators (2013), who showed that
infusing LDL-bound C24:0-ceramide to mice resulted in whole body and skeletal muscle insulin
resistance (Boon et al., 2013). Time-related changes in hepatic ceramides and glycosylated
ceramides of lean and overweight cows are shown in Figure 4-11 and Figure 4-16. Unexpectedly,
hepatic C24:0-ceramide content tended to be lower, while total ceramide was significantly lower
in overweight cows at d -24 prepartum. However, both C24:0-ceramide and total ceramide
73

increased toward parturition in overweight cows only (BCS × Day = 0.05; Figure 4-11) and were
68% and 62% higher by d 4 postpartum, respectively (P < 0.001). Moreover, regression analysis
revealed a positive linear relationship between liver and plasma ceramides (Figure 4-13; P <
0.001). Plasma C24:0- and total ceramide showed moderately high associations with hepatic
C24:0- and total ceramide (r = 0.54 and 0.63; P < 0.05). These results are in agreement with the
role of the liver as a source of circulating ceramides (Watt et al., 2012; Weisner et al., 2009), which
can reach organs such as the skeletal muscle and induce insulin resistance.
In the current study, hepatic fat accumulation was greater in overweight cows and it was
associated with increased plasma NEFA around parturition (unpublished data), indicating
accumulation of fatty acid substrates for ceramide synthesis. Along these lines, in a recent study,
Xia and collaborators (2015) demonstrated that ceramide accumulation can contribute to hepatic
steatosis and insulin resistance in mice, by promoting PKCζ activation and CD36-mediated lipid
uptake in the liver. In dairy cows, excessive lipomobilization results in elevated NEFA and is
associated with clinical fatty liver (Bobe et al., 2004; Ingvartsen, 2006). Moreover, we have
recently shown that increased NEFA is associated with elevated plasma ceramides (Rico et al.,
2015). Because plasma ceramide concentration was positively associated with liver lipid content
in the current study (e.g. C24:0-ceramide, r = 0.4; P < 0.05), it is likely that ceramide synthesis
and hepatic lipid accumulation are involved in a positive feedback cycle, by which increased fatty
acid availability promotes ceramide synthesis in the liver, and the resulting ceramides can further
promote uptake of circulating lipids. Future investigations should address this possibility by
evaluating the relationships between liver lipid accumulation, ceramides and fatty acid transport.
Time-dependent changes were observed for several skeletal muscle ceramides and
glycosylated ceramides, which increased during the transition from gestation to lactation (e.g.
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C16:0-, C22:0-ceramide, and 16:0-LacCer, P < 0.05). Overall, no significant differences in
ceramide accumulation were observed between lean and overweight cows, however, the
predominant C24:0-ceramide tended to be lower in overweight cows, relative to lean (P < 0.1;
Figure 4-12). Because ceramides have been reported to accumulate in obese individuals (Haus et
al., 2009), this result is unexpected. Although the reasons for this observation are unclear, we
propose that, in contrast to obese humans, overweight cows during the transition from gestation to
lactation suffer from decreased appetite and more severe negative energy balance, predisposing
them to excessive lipolysis and increased muscle catabolism and weight loss. Under such
metabolic state, it is conceivable that ectopic lipid accumulation, such as that of ceramide, is not
maximized. Despite this paradoxical result, the observation that ceramides and glycosylated
ceramides increased during peripartum demonstrates that increased ceramide accumulation occurs
in this period, concomitant with near-maximal plasma NEFA content (Samii et al., JDS, under
submission).
Considering that liver-derived ceramides can induce insulin resistance in monogastrics
(Summers et al., 1998, Boon et al., 2013; Chavez et al., 2014), we hypothesized that circulating
ceramides would be associated with direct measurements of insulin action. As expected,
significant inverse associations between postpartum glucose disappearance during ITT and
ceramides were detected, ranging 0.50 to 0.75 (P < 0.05; Figure 4-14), with the strongest
correlations observed for C18:0-ceramide (P < 0.001). Importantly, the strong associations
between ceramides and insulin sensitivity were observed during a period in which cows undergo
negative energy balance, inflammation, and extensive lipomobilization. Whether similar
observations can occur during established lactation and under positive energy balance is yet to be
established.
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In addition to their effects on insulin sensitivity, ceramides mediate the apoptotic effects of
fatty acids on pancreatic β cells and can cause reduced expression of the insulin gene, resulting in
reduced pancreatic insulin release (Shimabukuro et al., Sjoholm, 1998; Kleppe et al., 2003).
Because insulin secretion usually decreases as parturition approaches (Rico et al., 2015), we were
interested in evaluating the association between plasma insulin concentration and ceramide. An
inverse relationship between glycosylated ceramides and insulin in plasma was detected for several
glycosylated ceramides (r = -0.26 to -0.41; P < 0.001). Future investigations should determine
whether ceramides are mechanistically involved in the peripartal decrease of insulin secretion from
the pancreas.
Peripartal insulin resistance and lipolysis represent adaptive mechanisms that facilitate
necessary shifts in nutrient metabolism to support the elevated glucose demands of lactation.
Although ceramides have the ability to disrupt insulin signaling, their role in driving insulin
resistance during the transition from gestation to lactation is still unknown. By examining ceramide
accumulation and insulin sensitivity, we established that postpartum insulin resistance is
associated with increased ceramide. Furthermore, using a model of increased adiposity, we
demonstrated that overweight cows displayed elevated concentrations of circulating ceramides,
however, their ability to induce insulin resistance remains unknown. Future research we will need
to determine whether ceramide mediates insulin resistance in dairy cows, both physiologically and
pathologically. If a causal relationship is established, factors contributing to excessive ceramide
synthesis, such as inflammation and excessive adipose tissue mobilization, will require evaluation.
Our data suggest that sphingomyelin hydrolysis can be a major contributor to ceramide synthesis.
Therefore, special focus should be placed in the investigation of hepatic sphingomyelin
metabolism and its modulation to regulate ceramide accrual during peripartum.
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Conclusion
Our results support the association between ceramides and insulin resistance in peripartal
dairy cows. Moreover, the increased concentrations of ceramide and glycosylated ceramide in liver
and plasma of overweight dairy cows demonstrate that elevated body fat accumulation contributes
to the accumulation of these sphingolipids. Our targeted metabolomics approach revealed that
sphingolipid metabolism changes dynamically during the transition from gestation to lactation.
We conclude that temporal changes in sphingolipid metabolism results in active remodeling of the
plasma sphingolipidome, and result in ceramide accumulation, independent of body fat content.
We also conclude that ceramide tissue accumulation occurs progressively during the transition
from gestation to lactation, and is associated with NEFA and sphingomyelin availability. Our data
show that ceramide accumulation during peripartum is associated with the homeorhetic reduction
of insulin action postpartum, supporting a role for ceramides in facilitating the physiological
adaptations during this period. To confirm this possibility, further studies should investigate
whether ceramide mediates the development of insulin resistance in dairy cattle. Furthermore, the
role of inflammation in driving sphingomyelin hydrolysis will need to be investigated, as
modulation of excessive ceramide accumulation could potential improve cow health during
peripartum.
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Table 4-1. Ingredients and nutrient composition of diets fed to lean and overweight cows during
the transition from late pregnancy to early lactation.
Diets
Ingredients, % of DM
Corn silage
Mixed grass haylage
Mixed grass hay
Dry ground corn
Prepartum mix1
Lactation mix A2
Aminoplus
Cottonseed with lint
Sugar cane syrup
Lactation mix B3
Close-up supplement4
Rumensin5
Nutrient Composition
DM, %
NDF, % of DM
Forage NDF, % of DM
Forage NDF, % of NDF
ADF, % of DM
CP, % of DM
Starch, % of DM
Ether extract, % of DM
Ash, % of DM

Prepartum
30.7
28.4
13.2
–
13.9
–
9.0
–
–
–
4.8
–

Lactation
42.4
7.0
2.1
14.4
–
14.0
4.7
4.5
3.6
4.5
2.7
0.1

55.5
48.3
43.7
90.5
32
12.2
14.1
3.2
7.5

51.6
37.6
25.1
66.7
25.2
16.5
21.2
4.3
7.3

1

Mix contained 27% commercial dry cow mix with Animate (Phibro Animal Health Corp., Teaneck, NJ),
17.3% ground corn, 17.3% crimped oats, 13% corn distillers, 12.9% soybean meal, 4.3% calcium
carbonate, 4.3% calcium sulfate, 2.6% Omnigen AF (Phibro Animal Health Corp.), 1.1 Monocalcium
phosphate, and < 1% of each of the following: Sel-plex 600 (Alltech Biotechnology, Nicholasville, KY)
and vitamin E. 2Mix contained 33.6% citrus pulp, 19% soybean meal. 15.6% canola meal, 14% soybean
hulls, 4.5% calcium carbonate, 4.5% sodium bicarbonate, 2.8% urea, 2.7% fat, 2.4% sodium chloride, and
<1% from each of the following: Monocalcium phosphate, biotin, and Rumensin 90 (Elanco Animal
Health, Greenfield, IN). 3Mix contained 43.6% Fermenten (Church and Dwight Co., Princeton, NJ),
21.8% calcium carbonate, 10.8% soybean hulls, 7.8% Mintrex blend (Novus International Inc., St.
Charles, MO), 5.2% blood meal, 3.5% magnesium oxide, 2.6% Celmanax (Vi-COR, Mason City, IA),
2.6% Omnigen (Phibro Animal Health Corp.), and <1% of each of the following: vitamin E, selenium
selenite, and selenium yeast 600. 4Mix contained 74.5% ground oats, 15.3% commercial amino acid, 8%
Reashure (Balchem Encapsulates, Slate Hill, NY), and <1% of each of the following: vitamin E and
Niashure (Balchem Corporation, New Hampton, NY). 5Rumensin for dairy included at 4,890 mg/kg.
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Figure 4-1. Major pathways of ceramide synthesis.
De novo ceramide is initiated by the condensation of palmitoyl-CoA and serine, a pathway
upregulated by saturated fatty acids (SFA). Sphingomyelin hydrolysis results in ceramide
synthesis, a process induced by the inflammatory cytokine TNFα. Sphingolipids have various acyl
chain lengths and can differ in carbon length and degree of saturation. For simplicity, C24:0-linked
sphingolipids and glycosphingolipids are illustrated. Monohexosylceramides (GlcCer) consist of
a single sugar residue, either glucose or galactose (galactosylceramide is not shown).
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Figure 4-2. Plasma ceramides, monohexosylceramides (GlcCer), and lactosylceramides (LacCer)
are elevated in overweight dairy cows transitioning from gestation to lactation.
For visualization purposes, the heat map represents relative concentrations as high (red) or low
(blue). The heat map was generated using MetaboAnalyst 3.0 (Xia et al., 2015). Data are
represented as least squares means and their standard errors. ‡, main effect of day relative to
parturition, P < 0.05; ¥, P < 0.1. *, Treatment × Day interaction, P < 0.05; †, P < 0.10. DH: dihydro.
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Figure 4-3. Plasma ceramides change dynamically during the transition from gestation to lactation.
Plasma concentration of plasma total (A) ceramide, (B) GlcCer, and (C) LacCer in lean and
overweight transition dairy cows. Data are represented as least squares means and their standard
errors. *, P < 0.05; +, P < 0.10. Glc: Monohexosylceramide, LacCer: lactosylceramide,
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Figure 4-4. Plasma ceramides are elevated in overweight cows during the transition from gestation
to lactation.
Plasma concentration of (A) C16:0-, (B) C18:0-, (C) C20:0-, (D) C22:0-, (E) C22:1-, (F) C24:0-,
(G) C26:0-ceramide, and (H) C16:0-DH-ceramide in lean and overweight transition dairy cows.
Data are represented as least squares means and their standard errors. *, P < 0.05; +, P < 0.10. DH:
dihydro.
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Figure 4-5. Plasma concentrations (ng/mL) of monohexosylceramides (GlcCer) in lean and
overweight cows transitioning from gestation to lactation.
Plasma (A) C16:0-, (B) C16:1-, (C) C18:0-, (D) C18:1-, (E) C20:0-, (F) C22:0-, (G) C22:1, (H)
C24:0-, (I) C24:1-, and (J) C26:0-GlcCer, in lean and overweight transition dairy cows. Data are
represented as least squares means and their standard errors. *, P < 0.05; †, P < 0.10.
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Figure 4-6. Plasma concentrations (ng/mL) of lactosylceramides (LacCer) in lean and overweight
cows transitioning from gestation to lactation.
Plasma concentrations of (A) C16:0-, (B) C18:0-, (C) C22:0-, (D) C24:0-, (E) C20:0-, (F) C22:0, (G) C22:1, (H) C24:0-, (I) C24:1-, and (J) C26:0-LacCer in lean and overweight transition dairy
cows. Data are represented as least squares means and their standard errors. *, P < 0.05.
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Figure 4-7. Plasma sphingomyelin profile during the transition from gestation to lactation.
(A) Plasma profile of sphingomyelin and (B) temporal changes of plasma sphingomyelin in lean
and overweight cows. Data are represented as least squares means and their standard errors.*, P <
0.05; †, P < 0.10.
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Figure 4-8. Plasma sphingomyelins change dynamically in dairy cows transitioning from gestation
to lactation.
For visualization purposes, the heat map represents relative concentrations as high (red) or low
(blue). The heat map was generated using MetaboAnalyst 3.0 (Xia et al., 2015). Data are
represented as least squares means and their standard errors. ‡, main effect of day relative to
parturition, P < 0.05. §, main effect of adiposity (BCS), P < 0.05; *, Treatment × Day interaction,
P < 0.05; †, P < 0.10. DH: dihydro.
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Figure 4-9. Plasma sphingomyelins decrease toward parturition and increase postpartum.
Plasma concentrations (µg/mL) of (A) C16:0-, (B) C16:1-, (C) C18:0-, (D) C18:1-, (E) C20:0-,
(F) C22:0-, (G) C24:0-, and (H) C24:1-sphingomyelin in lean and overweight transition dairy
cows. Data are represented as least squares means and their standard errors. *, P < 0.05; †, P <
0.10.
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Figure 4-10. Ceramide profile of liver and skeletal muscle at d 4 postpartum.
Ceramide profile in (A) liver and (B) skeletal muscle. Data are represented as means and their
standard deviations.
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Figure 4-11. C24:0-ceramide and total ceramide hepatic accumulation increase in overweight cows
during the transition from gestation to lactation.
Hepatic concentrations (µg/mg liver) of (A) C16:0-, (B) C18:0-, (C) C20:0-, (D) C22:0-, (E)
C24:0-, (F) C26:0-, and (G) total ceramide in lean and overweight transition dairy cows. Data are
represented as least squares means and their standard errors. *, P < 0.05; †, P < 0.10.
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Figure 4-12. C24:0-ceramide and total ceramide content of skeletal muscle during the transition
from gestation to lactation.
Skeletal muscle concentrations (µg/mg tissue) of (A) C16:0-, (B) C18:0-, (C) C20:0-, (D) C22:0, (E) C24:0-, (F) C26:0-, and (G) total ceramide in lean and overweight transition dairy cows. Data
are represented as least squares means and their standard errors. *, P < 0.05; †, P < 0.10.
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Figure 4-13. Plasma ceramide content is associated with hepatic ceramide accumulation
postpartum.
Simple linear regression analysis between plasma and liver concentrations of (A) C24:0-ceramide
and (B) total ceramide in lean and overweight dairy cows at d 4 postpartum.
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Figure 4-14. Circulating ceramides are inversely associated glucose disappearance during an
insulin challenge at d 4 postpartum.
Pearson’s ranked correlations of circulating ceramides and glucose disappearance during ITT.
**, P < 0.01; *, P < 0.05; †, P < 0.10. ITT: Insulin tolerance test; DH: Dihydro.
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Figure 4-15. Supplemental Figure 1. Plasma dihydro-sphingomyelins (DH) decrease toward
parturition and increase postpartum.
Plasma concentrations (µg/mL) of (A) C16:0-, (B) C18:0-, (C) C20:0-, and (D) total
sphingomyelin in lean and overweight transition dairy cows. Data are represented as least squares
means and their standard errors. *, P < 0.05; †, P < 0.10.
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Figure 4-16. Supplemental Figure 2. Monohexosylceramide (GlcCer) and lactosylceramide
(LacCer) profile of liver and skeletal muscle at d 4 postartum.
Hepatic profile of (A) GlcCer and (B) LacCer, and skeletal muscle profile of (C) GlcCer and (D)
LacCer. Data are represented as means and their standard deviations.
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Chapter 5
PALMITIC ACID FEEDING INCREASES CERAMIDE AVAILABILITY IN
ASSOCIATION WITH INCREASED MILK YIELD, NEFA AVAILABILITY, AND
ADIPOSE TISSUE RESPONSIVENESS TO A GLUCOSE CHALLENGE.

Abstract
Reduced insulin action is a key adaptation that facilitates glucose partitioning to the
mammary gland for milk synthesis during early lactation, an adaptation occurs in parallel with
enhanced adipose tissue lipolysis. The progressive recovery of insulin sensitivity as cows advance
toward late lactation is accompanied by reductions in circulating non-esterified fatty acids (NEFA)
and milk yield. Because palmitic acid can promote insulin resistance in monogastrics through
sphingolipid ceramides-dependent mechanisms, C16:0 feeding may enhance milk production by
restoring homeorhetic responses. We hypothesized that C16:0 feeding would enhance ceramide
availability in mid-lactation dairy cattle, and ceramide would be positively associated with milk
yield. Twenty multiparous mid-lactation Holstein cows were enrolled in a study consisting of a 5
d covariate, 49 d treatment, and 14 d post-treatment period. All cows received a common sorghum
silage-based diet and were randomly assigned to a diet containing no supplemental fat (control; n
= 10; 138 ± 45 DIM) or C16:0 at 4% of ration DM (PALM; 98% C16:0; n = 10; 136 ± 44 DIM).
Blood and milk were collected at routine intervals. Liver and skeletal muscle tissue were biopsied
at d 47 of treatment. Intravenous glucose tolerance tests (300 mg/kg of body weight (BW); GTT)
were performed at d -1, 21, and 49 relative to start of treatment. The plasma and tissue
concentrations of ceramide and glycosylated ceramide were determined using liquid
chromatography-based mass spectrometry. Data were analyzed as repeated measures using a
mixed model with fixed effects of treatment and time, and milk yield served as a covariate. Cows
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fed PALM experienced an increase in milk yield, energy-corrected milk (ECM), and milk fat yield.
The most abundant plasma and tissue sphingolipids detected were C24:0-ceramide, C24:0monohexosylceramide (GlcCer), and C16:0-lactosylceramide (LacCer). Plasma concentrations of
total ceramide and GlcCer decreased as lactation advanced, and ceramide and GlcCer were
elevated in cows fed PALM. Feeding PALM increased hepatic ceramide levels, a response not
observed in skeletal muscle tissue. Plasma ceramides (e.g., C24:0-ceramide) were positively
correlated with plasma NEFA and milk yield, and inversely correlated with NEFA disappearance
following a glucose challenge. Our data demonstrate a remodeled plasma and hepatic
sphingolipidome in dairy cows fed PALM.

Introduction
The development of insulin resistance in adipose and skeletal muscle tissues enables the
dairy cow to partition glucose toward the mammary gland during early lactation (Bell, 1995; Bell
and Bauman, 1997). As a consequence, a decrease in insulin sensitivity can enhance the
mobilization of non-esterified fatty acids (NEFA) from adipose tissue (Contreras et al., 2010;
Zachut et al., 2013). NEFA can undergo mitochondrial β-oxidation in peripheral tissues, and reesterification in the mammary gland to contribute to milk fat synthesis. These coordinated
metabolic adaptations support energy demand as milk production rapidly increases following
parturition. Beyond peak milk yield, insulin sensitivity improves and the lipolytic release of NEFA
decreases as the cow progresses toward late lactation and milk production steadily declines
(McNamara and Hillers, 1986; Bell and Bauman, 1997).
A causal relationship between enhanced FA availability and the development of insulin
resistance in dairy cattle has been repeatedly observed (Pires et al., 2007a, b; Rico et al., 2015).
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For instance, the intravenous infusion of tallow emulsion or suppressing adipose tissue lipolysis
during feed restriction can improve insulin responsiveness (Pires et al., 2007a; b). In type 2 diabetic
monogastric animal models, sustained hyperlipidemia shifts FA processing toward the hepatic
synthesis and lipoprotein secretion of sphingolipid ceramide (Watt et al., 2012; Boon et al., 2013).
Interestingly, de novo ceramide synthesis is controlled by the availability of saturated palmitoylCoA and the activation of serine palmitoyltransferase-1 (SPT1; Figure 5-1; Watt et al., 2012). The
accrual of ceramide can antagonize insulin-stimulated glucose uptake by inhibiting the
phosphorylation of protein kinase B (Akt; Summers et al., 1998; Chavez et al., 2003). With the
advent
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sphingolipid
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and

monohexosylceramide (glucosylceramide or galactosylceramide; GlcCer) have emerged as
predicative biomarkers for the development of insulin resistance (Chavez et al 2014). Similar to
the progression of the diabetic state in humans (Kautzky-Willer et al., 1997), we recently
discovered that the decline in insulin sensitivity with the onset of lactation occurs concomitantly
with the accumulation of ceramide in plasma (Rico et al., 2015). For example, we and others have
observed a positive relationship between the availability of FA and the sphingolipid subspecie
C24:0-ceramide in plasma, and the severity of insulin resistance (Haus et al., 2009; Rico et al.,
2015); however, the relationship between FA and ceramide supply, and milk production in context
of homeorhetic nutrient partitioning have not be evaluated in the mid-lactation dairy cow.
Feeding dairy cows diets containing supplemental SFA is a common nutritional approach
to increase energy intake and milk yield during mid-lactation (Lock, et al., 2013; Rico et al., 2014a,
b). Highly enriched SFA supplements are utilized by dairy producers because of their minimal
effects on rumen microbial activity (Palmquist and Jenkins, 1980; Jenkins, 1993; Maia et al., 2010)
and because of their beneficial milk production response as compared with unsaturated FA (UFA)
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supplementation (Christensen et al., 1994; Relling and Reynolds, 2007), particularly in highproducing dairy cows (Rico et al., 2014b). Although SFA feeding increases dietary energy,
favorable lactation outcomes may not completely depend on the energy content of the SFA. For
instance, feeding palmitic acid (C16:0) increases energy-corrected milk and milk fat yield when
compared with C18:0 supplementation (Rico et al., 2014a). It is accepted that long-chain SFA are
antagonists of insulin action in monogastric animals (Boden, 1997; Funaki, 2009), a response that
is mediated by ceramide-dependent Akt inactivation (Summers et al., 1998; Chavez et al., 2003).
Because SPT1 upregulation is dependent upon palmitoyl-CoA availability (Figure 5-1), feeding
mid-lactation dairy cows C16:0 may upregulate de novo ceramide synthesis. Humans consuming
a diet high in C16:0, relative to oleic acid, display increased circulating levels of ceramide (Kein
et al., 2013), resembling upregulated ceramide synthesis observed in subjects diagnosed with type
2 diabetes (Haus et al., 2009). Although we and others have not observed changes in systemic
glucose tolerance in dairy cows fed C16:0 when compared with unsupplemented control cows
(Piantoni et al., 2013; Mathews et al., JDS Submitted), we have observed a decrease in glucosestimulated NEFA disappearance in mid-lactation cows fed C16:0 (Mathews et al., JDS Submitted),
suggesting the possibility of localized adipose tissue insulin resistance with C16:0 feeding. The
unexplored metabolic fates for absorbed C16:0, and the associative and functional role of ceramide
to modify insulin sensitivity in response to C16:0 supplementation merits attention.
The objective for the current study was to employ a targeted metabolomics approach to
quantify ceramides, GlcCer, and lactosylceramides (LacCer) in plasma, and liver and skeletal
muscle tissues collected from mid-lactation dairy cows supplemented with high-purity C16:0 for
an extended duration, in comparison with a non-added fat control. We hypothesized that increasing
dietary C16:0 would enhance ceramide synthesis, and ceramide availability would be positively
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associated with milk yield. Because insulin sensitivity improves and lipolysis is suppressed as
lactation advances towards late gestation (McNamara and Hillers, 1986; Bell and Bauman, 1997),
we expected control cows to exhibit a decline in circulating ceramide as lactation progressed.

Materials and Methods

Experimental Design
Experimental procedures were approved by the West Virginia University Institutional
Animal Care and Use Committee at West Virginia University (Morgantown). Twenty multiparous,
mid-lactation Holstein cows were housed in a free-stall barn and trained to access feed by using
Calan gate feeders (American Calan, Inc., Norwood, NH) at the West Virginia University Animal
Science Farm. Diets were mixed and offered twice daily. Access to feed was blocked from 0800
to 1000 h and 1600 to 1700 h to allow for orts collection and feeding. Cows were fed at 110% of
expected intake, adjusted daily, and provided free access to water. Cows were milked twice daily
at 0800 and 1800 h. Milk yield was recorded daily.
All cows received a common TMR for 14 d prior to experimentation. During a 5 d covariate
period, all cows received a common TMR without supplemental fat. Following the covariate
period, cows were grouped by DIM and milk yield (136 ± 43 DIM, 24.8 ± 4.9 kg of milk/d), and
offered a similar TMR consisting of no added fat (control; soyhull pellets; n = 10) or supplemented
with palmitic acid (PALM; Palmit 98; Global Agri-Trade, Long Beach, CA; n = 10) provided at
4% ration DM for 49 d. Post-treatment, all cows were fed a common TMR for 14 d. Diets provided
were composed of sorghum silage and alfalfa haylage as the main forage components, and were
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formulated to meet nutrient recommendations (Table 5-1; NRC, 2001). Forages and concentrates
were collected weekly, stored at -20°C, and composited at trial completion.
Blood collection (10 mL) by coccygeal venipuncture occurred on d -3, -2, and 0 of the
covariate period, and d 4, 6, 8, 14, 17, 21, 22, 24, 31, 38, 47, and 49 of the treatment period. In
addition, blood was collected on d 52, 56, 62, and 63, relative to the initiation of treatment to
characterize the post-treatment period. Blood was kept on ice for 30 min until centrifugation at
3,400 × g for 10 min. Following centrifugation, EDTA-preserved plasma was removed and stored
at -80°C until further analysis. Liver, skeletal muscle, and adipose tissue biopsies were performed
on d -3 and 47 relative to the start of treatment using aseptic techniques. For tissue biopsies, cows
were anesthetized with xylazine (0.04 mL/kg of BW) delivered via the coccygeal vein. After the
hair was clipped, biopsy sites were sanitized with iodine scrub and anesthetized with a 5 mL of
lidocaine HCl (Vedco Inc., Saint Joseph, MO) delivered subcutaneously. For liver biopsies, the
11th intercostal space was prepared by making a 0.5 cm incision through the skin, and a fabricated
trocar was utilized to collect approximately 1 g of liver tissue (Hughes, 1962). Skeletal muscle
biopsies were performed by making a 0.5 cm incision in the skin adjacent to the semitendinosus
muscle. Approximately 500 mg of muscle was collected using a Bard Magnum biopsy instrument
mounted with a 12 gauge needle (Bard Biopsy Systems, Tempe, AZ). Following the collection of
tissue, biopsy sites were stapled and sprayed with antiseptic, and Excenel RTU was delivered once
by intramuscular injection (0.68 mL/, kg of BW; Zoetis, Florham Park, NJ). Tissue for ceramide
profiling was snap-frozen in liquid nitrogen and stored at -80°C. Tissue for PCR analysis was
stabilized using RNAlater (Thermo Fisher Scientific Inc, Waltham, MA), refrigerated at 4°C
during 24 h, and stored at -20°C until RNA isolation was performed.
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Glucose Tolerance Tests
Glucose tolerance tests (GTT) were performed on d -1, 24, and 49, relative to the start of
treatment using previously described methods (Pires et al., 2007a; Schoenberg et al., 2012).
Briefly, a jugular catheter was inserted 24 h prior to the GTT, and patency was maintained by
flushing with heparinized saline every 12 h. Coinciding with the removal of feed at 0800 h, cows
were intravenously infused with 300 mg of glucose (dextrose, 50% wt/vol) per kg of BW. Glucose
infusion occurred within 8 ± 0.88 min, and was followed by a 10-mL saline flush. Blood samples
(10 mL) were collected at -10, 0, 10, 20, 30, 40, 60, 90, 120, 150, and 180 min relative to initiation
of glucose infusion. Blood was processed as described above. Feed was provided immediately
following the completion of the GTT. The area under the curve for NEFA during GTT was
calculated using the trapezoidal method as previously described by others (Pires et al., 2007a).

Sample Analyses
Individually composited feed ingredients were analyzed for NDF with heat-stable αamylase and sodium sulfite (Van Soest et al., 1991), CP (AOAC International, 2000; method
990.03), and starch (Hall, 2009) by Cumberland Valley Analytical Services Inc. (Cumberland,
MD).
To evaluate the relationship between ceramide and NEFA availability, we measured the
concentrations of NEFA in plasma using an enzymatic method (HR series NEFA-HR; Wako
Chemicals USA Inc., Richmond, VA). Spectrophotometric measurements were conducted using a
SpectraMax Plus 384 Microplate Reader (Molecular Devices, Sunnyvale, CA). Intra- and
interassay CV were 3.7 and 3.7% for plasma NEFA.
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Plasma ceramide extraction was conducted using previously established methods that
employ a modified Bligh and Dyer procedure including ceramide C12:0 as an internal standard
(Avanti Polar Lipids, Alabaster, AL; Haughey, et al., 2004; Bandaru et al., 2013; Rico et al., 2015).
Briefly, plasma extracts were dried using a nitrogen evaporator and re-suspended in pure methanol
for analysis. Sample extracts were handled using an autosampler (LEAP technologies Inc.,
Carrboro, NC) that introduced extracts into an HPLC (PerkinElmer, Boston, MA) with a C18
reverse-phase column (Phenomenex, Torrance, CA). Individual species of ceramide were
separated by gradient elution and injected into an electrospray ion source coupled to a triple
quadrupole mass spectrometer (API3000; AB Sciex Inc., Thornhill, Ontario, Canada; (Bandaru et
al., 2007; Bandaru et al., 2011; Bandaru, 2013). Ion spray voltage was 5500 V at a temperature of
80◦C with a nebulizer gas of 8 psi, curtain gas 8 psi, and collision gas 4 psi. Declustering potential
was 80 V, focusing potential 400 V, entrance potential 10 V, collision energy 30 V, and collision
cell exit potential 18 V. Individual ceramide species were detected by multiple reaction
monitoring. Six point calibration curves (0.1 to 750 ng/ml) were constructed by plotting area under
the curve for each calibration standard, C16:0-, C18:0-, C20:0-, C22:0-, and C24:0-ceramide,
normalized to C12:0-ceramide. Sphingolipid concentrations were determined by curve fitting the
identified ceramide species based on acyl-chain length. Quantification of spectral data was
performed using Analyst 1.4.2 and MultiQuant software (AB Sciex Inc., Thornhill, Ontario,
Canada).
To evaluate changes in hepatic gene expression, RNA isolation and real-time PCR were
performed. RNA was extracted from frozen tissues using Trizol reagent (Invitrogen, Carlsbad,
CA) according to manufacturer’s instructions. Pellets of RNA were resuspended in RNase-free
water and quantified at 260 nm using a spectrophotometer. Total RNA (1 µg) was reverse
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transcribed into cDNA using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) according
to manufacturer’s instructions. Realt-time PCR reactions were performed using the SYBR Green
Master Mix qPCR kit (Bio Rad, Hercules, CA) and a CFX96 Real-time PCR machine (Bio-Rad,
Hercules, CA). Quantification of gene transcripts for serine palmitoyltransferase 1 (SPT-1),
ceramide synthases 1-6 (CerS1-6) and acid sphingomyelinase (SMase) was completed using genespecific primers (Supplemental Table 2). Ribosomal protein S9 (RPS9) was utilized as the
endogenous control genes. Reaction conditions were as follows: 50 cycles of 95°C for 3 min, 95°C
for 30 s, 60°C for 30 s, and 72°C for 30 s, followed by 95°C for 1 min, 60°C for 1 min, and a
temperature gradient from 60°C to 95°C in increments of 5°C.

Statistical Analysis
All plasma data were analyzed as repeated measures over time relative to start of treatment
under the MIXED procedure of SAS (version 9.3; SAS Institute Inc.). The statistical model
included the random effect of cow, and the fixed effects of treatment and day relative to treatment
start, and their interaction. The most appropriate covariance structure for the repeated measures
analysis was selected for each variable after evaluating 5 different covariance structures (variance
components, first-order autoregressive, heterogeneous first-order autoregressive, compound
symmetry, and heterogeneous compound symmetry), and the structure with the smallest Akaike’s
information criterion coefficient was selected for analysis. Modeling of the covariance structure
allowed the identification of patterns that best describe relationships between the repeated
measures in the model. The method of Kenward-Rogers was used for calculation of denominator
degrees of freedom. Normality of the residuals was evaluated with normal probability and box
103

plots and homogeneity of variances with plots of residual versus predicted values. When necessary,
data were transformed. Preplanned contrasts were used to evaluate the differences between
treatments at each time point. Differences between treatments for tissue data were analyzed using
the GLM procedure of SAS. Studentized residual values > 3.0 or < -3.0 were considered outliers
and removed from the analysis (typically 1 per response variable). Parametric Pearson correlations
were performed in order to determine associations between plasma ceramides and milk yield,
plasma NEFA and NEFA disappearance during glucose tolerance testing. All results are expressed
as least squares means and their standard errors, unless stated otherwise. Significance was declared
at P < 0.05 and trends at P < 0.10.

Results and Discussion
The development of insulin resistance is associated with the accumulation of liver-derived
sphingolipid ceramide in plasma collected from hyperlipidemic type 2 diabetic animal models and
dairy cows transitioning from gestation to lactation (Haus et al., 2009; Watt et al., 2012; Rico et
al., 2015). Ceramides can be formed by de novo synthesis initiated by the condensation of
palmitoyl-CoA via action of serine palmitoyltransferase I (Figure 5-1). Because palmitoyl-CoA is
the principal substrate for de novo ceramide synthesis, we evaluated the effects of feeding an
enriched C16:0 supplement to mid-lactation dairy cows for an extended duration, relative to a
control without supplemental fat. The C16:0-enriched fat supplement was included at 3.9% of
ration DM for PALM treatment, with soyhulls substituted in the control treatment (Table 5-1). A
high dietary supply of C16:0 was used as a means to obtain a high fat diet (1.5-fold higher crude
fat relative to control) that could induce elevated ceramide synthesis. Content of DM of NDF, ether
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extract, CP, starch, and net energy for lactation were closely matched between treatments (Table
5-1). To measure changes in circulating and tissue ceramide levels, we employed liquid
chromatography coupled with mass spectrometry to perform a sphingolipidomic analysis of
plasma ceramides and glycosylated ceramides, an approach described by Merrill et al. (2009) and
utilized previously by our research group (Rico et al., 2015).
Detailed production and metabolic responses are described by Mathews et al. (J. Dairy
Sci., Submitted). Briefly, PALM elevated energy intake, milk yield, ECM, milk fat and protein
yield, and increased C16:0 incorporation in milk fat, relative to control. Estimated insulin
sensitivity was lower during the first week of PALM treatment; however, glucose disposal
following GTT was not modified during the duration of treatment. Although plasma NEFA
declined with the progression of lactation, we did observe enhanced basal plasma NEFA and
reduced glucose-stimulated NEFA disappearance by wk 7 of PALM treatment, suggesting
localized adipose tissue insulin resistance and enhanced lipolysis in mid-lactation cows
supplemented with C16:0.
The acyl chain diversity of sphingolipid ceramide is attributed to the action of six ceramide
synthases (Figure 5-1; Park and Pewzner-Jung, 2013). Using a targeted metabolomics approach
we quantified 21 ceramides, GlcCer, and LacCer in plasma, and liver and skeletal muscle tissue
(Figure 5-2 and 5-3, and Figure 5-9). Comparable to diabetic humans (Haus et al., 2009) and our
previous evaluation of insulin resistant peripartal dairy cows (Rico et al., 2015), C24:0-ceramide,
C24:0-GlcCer, and C16:0-LacCer represented the major plasma and liver sphingolipids in each
class. For instance, C24:0-ceramide represented approximately 70% of total ceramide measured
in plasma. Lignoceroyl sphingosine (C24:0-ceramide) is a bioactive lipid mediator that can
antagonize insulin-stimulated glucose uptake in mice and is elevated in type 2 diabetic humans
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(Boon et al., 2013; Haus et al., 2009). Because approximately 98% of plasma ceramides are found
within liver-derived lipoprotein subfractions (i.e., high, low, and very low density
lipoproteins; Lightle et al., 2003; Boon et al., 2013), we measured the concentrations of ceramides
in the liver. As expected, our results demonstrate that C24:0-ceramide is the predominant hepatic
ceramide. Recent evidence demonstrates that ceramides contained in low density lipoproteins are
elevated in a type 2 diabetic state, promote macrophage inflammation, and reduce insulinstimulated glucose uptake in cultured myocytes (Boon et al., 2013). Boon and coworkers (2013)
further demonstrated that ceramide is elevated in plasma membrane-enriched fractions of skeletal
muscle obtained from mice infused with low density lipoprotein (LDL)-ceramide, a response
accompanied by a reduction in Akt phosphorylation and insulin-stimulated glucose disposal.
Although we did not measure adipose tissue ceramide levels, we did quantify the concentrations
of ceramides and glycosylated ceramides in skeletal muscle. Our results reveal that C24:0ceramide is also the most abundant ceramide in skeletal muscle tissue, similar to our observed
plasma profile, and to skeletal muscle measurements made in monogastrics (Haus et al., 2009;
Boon et al., 2013). Relative to other ceramide subspecies, the biological importance of C24:0ceramide in plasma and tissues is unknown in ruminant animals.
Plasma ceramides are commonly elevated in insulin resistant humans experiencing
hyperlipidemia, and mostly represent the hepatic ceramide output (Haus et al., 2009, Watt et al.,
2012). Therefore, we compared the plasma ceramide and glycosylated ceramide profiles in coltrol
and PALM cows (Figure 5-5). In agreement with our hypothesis, PALM increased the
concentrations of total ceramide in plasma by d 7 of treatment (Figure 5-6; P < 0.01). The increase
in circulating total ceramide was primarily due to C24:0-ceramide accumulation. Specifically, the
concentration of C24:0-ceramide in plasma increased by d 7 and remained elevated for the duration
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of PALM feeding (80% increase on average; Figure 5-6; P < 0.001). Likewise, concentrations of
C16:1-, C22:0-, C22:1-, C24:1-, and C26:0-ceramide were greater in PALM-fed cows (Figure 56; P < 0.05). Following the removal of PALM, C16:1-, C22:0-, C22:1-, C24:0-, C24:1-, and
C26:0-ceramide concentrations in plasma returned to control levels, although total ceramide
tended to remain elevated (P = 0.09). We previously demonstrated that plasma concentrations of
total ceramide and C24:0-ceramide increase concomitantly with NEFA mobilization and the
development of insulin resistance as dairy cattle transition from gestation to lactation (Rico et al.,
2015). Beyond peak milk production, insulin sensitivity improves and lipogenesis is favored as
cows progress towards late lactation (McNamara and Hillers, 1986). In the present study, we
observed a gradual decline in the availability of many circulating ceramides as control cows
progressed through lactation, a response that was delayed with PALM. Interestingly, our observed
decline in plasma ceramide occurred concurrently with a steady decrease in NEFA supply
(Mathews et al., J. Dairy Sci. (Submitted)). In humans and rodents, increased availability of NEFA
can promote insulin resistance by promoting ceramide accumulation in plasma and peripheral
tissues (Adams et al., 2004; Holland et al., 2007; Watt et al., 2012). Our data supports a decrease
in ceramide synthesis as mid-lactation cows advance towards late gestation, a response that is
suppressed with continuous PALM feeding. Because ceramide synthesis is controlled by
palmitoyl-CoA availability, the efficacy of other energy sources (i.e. other SFA or carbohydrates)
to promote ceramide synthesis remains to be determined.
Glycosylated ceramides include GlcCer and LacCer, glycosphingolipids synthesized from
ceramide

and

precursors

for

monosialodihexosylganglioside

synthesis

(GM3,

a

ganglioside; Figure 5-1). Similar to ceramide, GlcCer levels are elevated in plasma collected from
insulin-resistant rodents (Chavez et al., 2014), and feeding a diet high in saturated fat can increase
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GlcCer availability (Aerts et al., 2007). In our experiment, PALM feeding increased total GlcCer
and C24:0-GlcCer levels in plasma 32 and 33% by wk 3 and 7, respectively (Figure 5-5 and 5-7;
P < 0.001), a response that was not observed following post-treatment. Similar increases C16:0-,
C22:0-, C22:1-, and C24:1-GlcCer in plasma were also observed with PALM treatment (Figure 57); however PALM did not change total or individual LacCer levels in plasma (Figure 5-5 and
Figure 5-9). Comparable to our observed changes in ceramide with time, we measured a gradual
decline in the majority of GlcCer and LacCer as lactation progressed. For example, C24:0-GlcCer
and C24:0-LacCer decreased 28 and 25% by wk 9 of experimentation, relative to the start of the
study (Figure 5-7 and Figure 5-9; P < 0.05). Similar to our previous work investigating ceramide
availability in periparturient dairy cows (Rico et al., 2015), we observed a strong positive
association between C24:0-ceramide and C24:0-GlCer across all sampled cows (Figure 5-10; P <
0.001). These results continue to support a coordinated regulation of synthesis for these
sphingolipids containing the C24:0 acyl moiety in dairy cows.
Evaluating the relationship between plasma and liver ceramides is a means to study
sphingolipid metabolism because circulating ceramides are incorporated within lipoproteins
(Lightle et al., 2003; Watt et al., 2012; Boon et al., 2013). Coinciding with the elevation in
circulating ceramide with PALM treatment, we detected an increase in total ceramide, C22:0-,
C22:1-, C24:0-, C24:1- and C26:0-ceramide within liver tissue collected at wk 7 (Figure 5-3; P <
0.05). We recently proposed that hepatic ceramide synthesis is likely upregulated in dairy cows
transitioning from gestation to lactation because of an increase in NEFA availability (Rico et al.,
2015). The de novo synthesis of ceramide is controlled by SPT1 and CerS (Figure 5-1). Although
feeding mid-lactation dairy cows C16:0 did not change the mRNA expression of SPT1 at d 47 of
treatment (Figure 5-8); CerS2 and CerS5 mRNA were lower with PALM treatment. Because each
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isoform may control the synthesis of specific ceramides, we characterized the isoform distrubution
in liver (Figure 5-8). While CerS6 was the predominant isoform, CerS2 and CerS5 mRNA were
expressed equally. Interestingly, CerS2 and CerS6 can control the synthesis of abundant C24:0and C16:0-ceramide, respectively (Levy and Futerman, 2010). An alternative route for ceramides
synthesis requires the activation of SMase to catalyze the hydrolysis of sphingomyelin, a response
that is often accompanied by inflammation (Yang et al., 1993; Kolesnick and Golde, 1994; Peraldi
et al., 1996). In our investigation, PALM decreased hepatic SMase mRNA expression (Figure 58). Considering that ceramide levels were elevated in liver and serum, reduced CerS and SMase
mRNA expression may be a negative feedback mechanism to lower ceramide availability with
extended PALM feeding. In addition to our observed changes with PALM feeding, our data also
suggests that the decline in NEFA from mid to late lactation is accompanied by a decrease in
hepatic ceramide synthesis and lipoprotein ceramide secretion, a response that is reversed during
the acceleration of NEFA mobilization observed during early lactation (McNamara, 1991; Rico et
al., 2015). Although the mechanisms involved in the transport of sphingolipid from the liver to the
plasma are unknown in monogastrics and ruminants, current evidence suggests a role for
microsomal triglyceride transfer protein (Iqbal et al., 2015).
We did not observe changes in skeletal muscle concentrations of total ceramide, GlcCer,
or LacCer by wk 7 in PALM-fed cows (Figure 5-3). With the exception of C18:0-ceramide (23%
decrease; P < 0.05), PALM feeding did not change skeletal muscle concentrations of individual
ceramides or glycosylated ceramides (Figure 5-3). Intriguingly, infusing mice with LDL-ceramide
did not increase total ceramide levels in skeletal muscle (Boon et al., 2013); however, LDLceramide induced insulin resistance was accompanied by plasma membrane ceramide accrual. In
context of homeorhetic glucose partitioning toward the mammary gland, the ability of intracellular
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or extracellular ceramide to antagonize insulin action in skeletal muscle requires further
investigation in dairy cows.
We have previously demonstrated in peripartal dairy cows that ceramide is positively
correlated with plasma NEFA availability (Rico et al., 2015). To validate this relationship in our
current investigation, we performed a Pearson’s correlation analysis to identify significant
associations between individual sphingolipid species and plasma NEFA levels. With the exception
of C16:0-ceramide, all circulating ceramides, GlcCer, and LacCer were positively correlated with
plasma NEFA concentrations (P < 0.05). The strongest correlations were observed for C22:0-,
C24:0-, and C26:0-ceramide (0.41-0.53; P < 0.001). Comparably, our previous work has
demonstrated a remarkably similar relationship in peripartal dairy cows (Rico et al., 2015). Most
notably, C16:0-ceramide availability is not linked with NEFA supply. Because we observed
reduced glucose-stimulated NEFA disappearance by wk 7 of PALM treatment (Mathews et al.,
JDS (Submitted)), indicative of adipose tissue insulin resistance, we analyzed the correlative
relationship between circulating ceramide supply and NEFA area under the curve (AUC) during a
GTT (Table 5-2). Circulating ceramide and glycosylated ceramide were negatively correlated with
NEFA AUC (P < 0.05). For instance, total ceramide and C24:0-ceramide were negatively
correlated with NEFA AUC (-52 and -0.57, respectively; P < 0.001). Although the effect of longchain plasma ceramide on lipolysis has not be characterized in dairy cows, culturing 3T3-L1
adipocytes with exogenous hydrophilic C2:0-ceramide can increase lipolysis by suppressing
insulin-stimulated activation of cyclic nucleotide phosphodiesterase 3B (Mei et al., 2002). A
limitation of our current work is that we have not established the origin of circulating NEFA. It is
conceivable that under conditions of elevated lipid supply, such as those induced with elevated
dietary fat supplementation, the rates of peripheral tissue FA uptake may be limited relative to the
110

rate of delivery upon triacylglycerol hydrolysis by lipoprotein lipase in the blood capillaries. It is
also possible, as we posit here, that circulating NEFA may also be originated from lipolysis in the
adipose tissue, as a direct consequence of reduced insulin action.
Considering that ceramide induces insulin resistance in monogastrics (Summers et al.,
1998), and insulin resistance in skeletal muscle and adipose tissue facilitates glucose partitioning
to the mammary gland for milk synthesis (Bell, 1995; Spachmann et al., 2013), we hypothesized
that milk yield would be associated with the availability of circulating ceramide. As expected,
significant positive correlation coefficients between milk yields and the majority of ceramides and
glycosylated ceramides were detected ranging from 0.25 to 0.51 (P < 0.05; Table 5-2), with the
strongest correlations observed for C22:0-, C24:0-, and C26:0-ceramide (P < 0.001). It should be
noted that these strong relationships between circulating ceramides and milk yields were observed
in mid-lactation cows experiencing positive energy balance. Whether a similar observation occurs
in early lactation cows experiencing a greater magnitude of insulin resistance and lipolysis is
uncertain.
The development of insulin resistance and lipolysis represent coordinated shifts in
metabolism to support the onset of lactation, adaptations that fade with the progression of lactation.
Although ceramides are known effectors of insulin resistance in monogastrics, the ability of
ceramide to promote glucose partitioning toward the mammary gland is unknown. In our study,
we were able to demonstrate that PALM feeding was able to delay the decline in ceramide
availability with the advancement of lactation. Future research we will need to determine whether
ceramide mediates insulin resistance in dairy cows. If it is established that ceramide can antagonize
insulin action, then promoting C16:0 intake in dairy cattle may be a nutritional approach for cows
to stimulate a homeorhetic response beyond milk yield. We recognize that insulin resistance and
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NEFA mobilization during early lactation is accompanied by ceramide accrual (Rico et al., 2015);
therefore, we cautiously contemplate whether C16:0 supplementation could augment ceramide
supply and insulin resistance during early lactation, and inadvertently challenge metabolic health.
These uncertainties will need to be addressed with further investigation.

Conclusions
Our targeted metabolomics approach has revealed that long-term feeding of C16:0 to midlactation cows increased hepatic synthesis and plasma accrual of ceramide. The ability of increased
C16:0 intake to augment ceramide supply delayed the decline in ceramide supply observed with
the progression of lactation. We also conclude that an increase in ceramide supply is associated
with elevated basal NEFA, reduced adipose tissue NEFA disappearance to a glucose challenge,
and milk yield. In support of our previous work (Rico et al., 2015), our data suggests that ceramides
may be intrinsically involved in the homeorhetic adaptation to lactation. To confirm this
possibility, further studies should investigate whether ceramide mediates the development of
systemic or localized insulin resistance in dairy cattle, and how these relationships are influenced
by stage of lactation. Specific attention should be focused on highly abundant C24:0-ceramide.
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Table 5-1. Ingredients and nutrient composition (% of DM unless otherwise noted) of experimental
diets supplemented with palmitic acid (PALM; C16:0) and control (no added fat).
Item
Ingredient (% DM)
Sorghum sudangrass
Ground corn
Alfalfa haylage
Soybean meal
Soyhulls
Beet pulp pellets
Vitamin and mineral premix1
Protein blend2
Sodium bicarbonate
Zeolite
Limestone
C16:0-enriched fat supplement3
Nutrient composition
DM, %
CP, % DM
NDF, % DM
Forage NDF, % DM
Starch, % DM
Ether extract, % DM
Ash, % DM
NEL, Mcal/kg DM

Treatment
Control
PALM
30.3
29.1
15.7
11.4
6.6
2.9
0.63
1.60
0.97
0.48
0.32
0.0

30.1
28.9
15.5
11.3
3.6
2.8
0.60
1.60
0.95
0.46
0.29
3.9

59.6
17.8
33.6
24.8
21.7
2.8
12.6
1.4

59.8
17.3
31.6
24.8
21.6
6.7
13.1
1.5

1

Vitamin-mineral mix contained 14% Ca, 9.5% P, 6.3% Mg, 0.13% K, 0.78% S, 4% Na, 17.6% C, 4282
ppm Fe, 3000 ppm Zn, 590 ppm Cu, 1600 ppm Mn, 62 ppm Se, 53 ppm Co, and 31 ppm I, as well as 507
kIU Vit. A, 69 kIU Vit. D, and 1997.6 kIU Vit. E.
2
Protein blend contained 30.1% canola meal solvent, 1.05% smartamine (Adisseo, Antony, France),
11.1% corn gluten meal (60%), 45.7% soy plus, and 12.1% blood meal.
3
Palmitic acid supplement contained 98% palmitic acid (Palmit 98; Global Agri-Trade, Long Beach, CA,
USA).
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Figure 5-1. De novo ceramide synthesis.
Ceramide de novo synthesis initiated by the condensation of palmitoyl-CoA and serine to form 3ketosphinganine. For simplicity, only C24:0-linked sphingolipids and glycosphingolipids are
illustrated. Monohexosylceramides (GlcCer) consist of a single sugar residue, either glucose or
galactose (galactosylceramide is not shown).
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Figure 5-2. C24:0-ceramide is the most abundant ceramide in plasma, and liver and skeletal muscle
tissue of lactating dairy cows fed control or palmitic acid-supplemented diets (PALM).
Ceramide profile of (A) plasma, and (B) liver and (C) skeletal muscle tissue at d 47 of treatment.
C16:0-dihydro-lactosylceramide is not included. Data are represented as least squares means and
their standard errors.*, P < 0.05; †, P < 0.10.
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Figure 5-3. Palmitic acid-feeding (PALM) increases hepatic ceramide concentrations (ng/mg).
Liver concentration of (A) ceramide, (B) monohexosylceramide (GlcCer), and (C)
lactosyceramide (LacCer), and skeletal muscle concentration of (D) ceramide, (E) GlcCer, and (F)
LacCer in control and PALM-fed cows at d 47 of treatment. Data are represented as least squares
means and their standard errors. *, P < 0.05.

116

Figure 5-4. Plasma ceramides and monohexosylceramides (GlcCer) are elevated in palmitic acidfed (PALM) cows, relative to control cows.
For visualization purposes, the heat map represents relative concentrations as high (red) or low
(blue). The heat map was generated using MetaboAnalyst 3.0 (Xia et al., 2012). Data are
represented as least squares means and their standard errors. ‡, main effect of day relative to
treatment start, P < 0.05; *, Treatment × Day interaction, P < 0.05; †, P < 0.10. Abbreviation:
LacCer: Lactosylceramide; DH: dihydro.

117

Figure 5-5. Palmitic acid-feeding (PALM) increases total ceramide and monohexosylceramide
(GlcCer) concentrations (ng/mL) in plasma.
Plasma concentration of total (A) ceramide, (B) GlcCer, and (C) lactosyceramide (LacCer) in
control and PALM-fed cows. Dotted arrows denote the end of treatment period. Data are
represented as least squares means and their standard errors. *, P < 0.05; †, P < 0.10.
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Figure 5-6. Plasma concentration (ng/mL) of C24:0-ceramide is elevated in palmitic acid-fed
(PALM) cows, relative to control cows.
Plasma concentration of (A) C16:0-, (B) C16:1-, (C) C20:0-, (D) C22:0-, (E) C22:1-, (F) C24:0-,
(G) C24:1-, and (H) C26:0-ceramide. Dotted arrows denote the end of treatment period. Data are
represented as least squares means and their standard errors. *, P < 0.05; †, P < 0.10.
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Figure 5-7. Plasma concentration (ng/mL) of C24:0-monohexosylceramide (GlcCer) is elevated in
palmitic acid-fed (PALM) cows, relative to control cows.
Plasma concentration of (A) C16:0-, (B) C16:1-, (C) C18:0-, (D) C22:0-, (E) C22:1-, (F) C24:0and (G) C24:1-GlcCer. Dotted arrows denote the end of treatment period. Data are represented
as least squares means and their standard errors. *, P < 0.05; †, P < 0.10.
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Figure 5-8. Hepatic expression of ceramides synthase (CerS) and acid sphingomyelinase (SMase)
is lower in cows fed palmitic acid (PALM) for an extended duration, relative to control cows.
Effect of PALM on the hepatic mRNA expression of (A) SPT1 and (B) CerS, relative to control
cows. (C) Hepatic distribution of CerS1-6 mRNA. (D) Change in SMase mRNA expression.
Ribosomal protein S9 was used as the endogenous control gene and control CerS1 was used as the
calibrator for making relative comparisons across isoforms. Data are represented as least squares
means and their standard error bars calculated using the 2 - Δ Δ C t . An asterisk indicates a significant
difference in ΔCt from control. ND = Not detected. *, P < 0.05.
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Table 5-2. Plasma ceramides are positively correlated with circulating NEFA and milk yield, and
negatively associated with area under the curve of NEFA during a glucose challenge in dairy cows
during mid-lactation.
Milk yield
r
P-value
Ceramide
C16:0
C16:1
C20:0
C22:0
C22:1
C24:0
C24:1
C26:0
Total
GlcCer
C16:0
C16:1
C18:0
C22:0
C22:1
C24:0
C24:1
Total
LacCer
C16:0
C18:1
C22:0
C24:0
C24:1
Total
C16:0-DHLacCer

r

NEFA
P-value

AUC 180
r
P-value

0.19
-0.01
0.37
0.43
0.14
0.44
0.15
0.51
0.39

<0.10
0.91
<0.01
<0.001
0.24
<0.001
0.18
<0.001
<0.001

0.10
0.23
0.24
0.53
0.41
0.52
0.38
0.41
0.53

0.26
<0.01
<0.01
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

-0.19
-0.05
-0.31
-0.39
-0.34
-0.57
-0.19
-0.55
-0.51

0.16
0.72
<0.05
<0.01
<0.01
<0.001
0.14
<0.001
<0.001

0.00
-0.08
-0.22
0.42
-0.11
0.35
-0.09
0.08

0.99
0.49
<0.10
<0.001
0.33
<0.01
0.44
0.46

0.35
0.30
-0.23
0.35
0.19
0.29
0.24
0.34

<0.001
0.001
<0.01
<0.001
<0.05
<0.001
<0.01
<0.001

-0.17
-0.08
0.13
-0.53
-0.03
-0.39
0.01
-0.24

0.19
0.57
0.34
<0.001
0.80
<0.01
0.94
<0.10

0.25
0.06
0.31
0.36
-0.10
0.24

<0.05
0.62
<0.01
<0.01
0.38
<0.05

0.31
0.36
0.40
0.45
0.41
0.33

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

-0.46
-0.44
-0.55
-0.59
-0.41
-0.47

<0.001
<0.001
<0.001
<0.001
<0.01
<0.01

0.14

0.23

0.32

<0.001

-0.28

<0.05

Pearson’s correlations (r) of circulating ceramides to plasma NEFA, milk yield, and area under
curve (AUC) for 180 min following a glucose challenge. DH, dihydro; GlcCer,
monohexosylceramide; LacCer, lactosylceramide.
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Figure 5-9. Supplemental 5-1. Plasma concentration (ng/mL) of lactosylceramide (LacCer) in
control and palmitic acid-fed (PALM) cows.
Plasma concentration of (A) C16:0-, (B) C18:1-, (C) C22:0-, (D) C24:0-, (E) C24:1-, and (F)
C16:0-dihydro-LacCer. Dotted arrows denote the end of treatment period. Data are represented as
least squares means and their standard errors. *, P < 0.05; †, P < 0.10.
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Figure 5-10. Supplemental 5-2. Plasma C24:0-monohexosylceramide (GlcCer) is positively
associated with C24:0-ceramide in lactating dairy cows.
Random regression analysis between plasma concentrations of C24:0-GlcCer and C24:0-ceramide
in lactating dairy cows fed control or palmitic acid-supplemented (PALM) diets. Coefficients of
determination (R2) represent the association between observed and model predicted values when
accounting for the random effect of cow. Data represent measurements for d 0, 23 and 49, relative
to start of treatment.
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Table 5-3. Supplemental 5-1. Nucleotide and PCR product specifications

Gene1

Sequence 5’-3’

18S-rRNA2

Fwd: TGCATGGCCGTTCTTAGTTG
Rv: AGAGTCTCGTTCGTTATCGGAATT

DQ222453

55

Product
length
(bp)
65

RPS9

Fwd : CCTCGACCAAGAGCTGAAG
Rv : CCTCCAGACCTCACGTTTGTTC
Fwd : CCCTCCGTTTTCTATGACTGG
Rv : AAGCATCCAGGTACAGTGTGG
Fwd : CCCTAACTTGGACCAGAAACC
Rv : CTGTCTGAGCAGTCCACATTG
Fwd : GGTTTAGGAGACGGCAGAATC
Rv e: CCCACAGGTCATATACCCAAG
Fwd : GGGAAAACTACCCACATCAGC
Rv : ACCTGCTCCTTGAAGTCCTTG
Fwd : CTGAACACGACCCTCTTTGAG
Rv : GACCAGATGACATGCAGAACC

DT860044

56

62

NM_001083514

60

120

NM_001034667

60

147

NM_001099389

60

144

NM_001015520

60

129

NM_001102132

60

107

Fwd : AGGCTTGAACTGCTTCTGGTC
Rv : GGTTCTTTCCTGGAGGTTCTG
Fwd : GAAGAGACCACTGGGTGTCG
Rv : ACCACAACCCTAATGCTCGG

NM_001193132

60

139

NM_001034749

60

149

CerS1
CerS2
CerS3
CerS4
CerS5
CerS6
SPT1

Gen Bank
accession no.

Tm
(C°)

1

18s rRNA = 18s ribosomal RNA; RPS9 = ribosomal protein S9; CerS1-CerS6 = ceramide synthases 1-6;

SPT1 = serine palmitoyltransferase subunit 1. All genes are specific to Bos Taurus.
2

Sequence from Janovick-Guretzky et al., 2007.
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Chapter 6
GENERAL CONCLUSIONS
With the experiments presented in this dissertation, we have evaluated the associations
between fatty acid availability, ceramide synthesis, and insulin action in dairy cows. Using mass
spectrometry, we have been able to comprehensively profile plasma and tissue sphingolipids
during pregnancy and lactation. This approach allowed us to identify meaningful patterns by which
the sphingolipidome is remodeled in association with parturition, the onset of lactation, as well as
with body fat accumulation. We established that sphingomyelin is the most abundant sphingolipid
in plasma, followed by ceramides and glycosylated ceramides. We conclude that both the
availability of circulating fatty acids and the accumulation of lipids in the liver can positively
influence the synthesis of ceramides and increase their accumulation in liver, plasma, and skeletal
muscle. We demonstrated that ceramide accumulation can be modulated by means of dietary
manipulation, and that increased availability of the saturated fatty acid palmitate can effectively
enhance ceramide synthesis. Moreover, our data suggest that circulating NEFA and sphingomyelin
contribute to ceramide synthesis during peripartum and established lactation, however, the relative
contributions from each pathway cannot be established from our results.
As expected, plasma ceramides were consistently inversely associated with insulin
sensitivity. The negative associations between ceramides and insulin sensitivity in lean and
overweight cows support the potential involvement of ceramide both in the homeorhetic
development of insulin resistance during peripartum, as well as in its pathological manifestation,
observed in hyperlipidemic overweight cows undergoing accelerated body weight loss and hepatic
fat accumulation. Moreover, our observations are in line with a role for ceramides in provoking
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adipose tissue-specific insulin resistance, as manifested by reduced rates of NEFA disappearance
in animal with elevated plasma ceramides.
Although these experiments provide useful information regarding the association between
ceramides, fatty acid availability and insulin resistance, future investigations will need to validate
our findings by directly evaluating the ability to ceramides to cause insulin resistance in diary
cows. Considering the large number of sphingolipids associated with NEFA, insulin sensitivity,
and milk production, future research should evaluate the potential use of ceramides and
sphingomyelins as predictors of metabolic risk and milk production. The manipulation of ceramide
synthesis and the identification of mechanism of insulin resistance constitute promising areas with
the potential to modulate productive responses, improve insulin sensitivity and to improve cow
health.
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